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DESIGN, SYNTHESIS AND CHARACTERIZATION OF ENDFUNCTIONALIZED GLYCO-POLYMER FOR EFFICIENT
PROTEOMIC ANALYSIS

SATYA NANDANA NARLA

ABSTRACT

Carbohydrates, especially, cell surface carbohydrates act as receptors for a variety
of ligands such as proteins and thereby play significant roles in physiological and
pathological processes, including cellular recognition and communication, bacterial and
viral infection, and tumor metastasis. As such, binding interactions of carbohydrates and
proteins have provided a starting point for the development of concept of isolation and
probing of proteins and cells in biological research and novel diagnostic agents as well as
new therapeutic applications. In this thesis study, oriented and multivalent carbohydrate
macromolecules were designed and developed based on a chain-end functionalized
carbohydrate-containing polymer (glycopolymer) for efficient protein analysis. Firstly,
O-cyanate chain-end functionalized glycopolymer was synthesized via cyanoxylmediated free-radical polymerization (CMFRP) in one-pot fashion. This glycopolymer
was tested for its oriented glyco-marcroligand formation and its glyco-affinity capturing
and glycanarray application by combining O-cyanate chain-end functionalized
glycopolymer with commercially available amine-functionalized silica gel and glass slide
v

via isourea bond formation, respectively. In the second study we demonstrated a new
type of glycan microarray, namely, oriented and density controlled glyco-macroligand
microarray based on end-point immobilization of glycopolymer that was accompanied
with boronic acid (BA) ligands in different sizes as detachable “temporary molecular
spacers”. The spaced glycopolymer microarray showed enhanced lectin binding
compared to non-spaced one.

Third, a chemoenzymatic synthesis of chain-end

functionalized sialyllactose-containing glycopolymers with different linkages was
performed and their oriented immobilization for glycoarray and SPR-based glycobiosensor applications were studied. Specifically, O-cyanate chain-end functionalized
sialyllactose-containing glycopolymers were synthesized by enzymatic α2,3- and α2,6sialylation of a lactose-containing glycopolymer and characterized by 1H NMR. They
were printed onto amine-functionalized glass slides for glycoarray formation. Specific
protein binding activity of the arrays were confirmed with α2,3- and α2,6-sialyl specific
binding lectins together with inhibition assays. In addition, sialyllactose glycopolymers
were immobilized on amine-modified SPR chip to study the specific binding activity of
lectins and influenza viral hemagglutinins (HA). These sialyloligo-macroligand
derivatives combined with oriental and density controlled glycan array and SPR-based
glyco-biosensor are closely to mimic 3D nature presentation of sialyloligosaccharides and
will provide important high-throughput tools for virus diagnosis and potential anti-viral
drug candidates screening application.

vi
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CHAPTER I

INTRODUCTION

1.1 Introduction
Carbohydrates envelop almost all living cell surfaces, mostly in the form of
glycoconjugates such as glycoptoteins, glycolypids and proteoglycans. These
carbohydrates on cell surface are playing significant roles in many biological processes,
such as, cell-cell signaling,1-2 immune recognition events,3 pathogen host interaction,4
tumor metastasis,5 tissue growth and repair,6 etc (Fig 1). Therefore, studying
carbohydrate binding interaction has provided a starting point for understanding the
molecular mechanisms that carbohydrate related and development of new therapies,7
protein and cell isolation,8 and targeted drug and gene delivery9 concept in biomedical
research and applications. It has been known that the carbohydrate-protein interactions
are significantly enhanced by multivalent carbohydrate ligands referred as “cluster
glycosidic effect”.10 In the past decades, variety multivalent carbohydrate ligands such as
glycopolymers, namely polymers with carbohydrate pendent groups, have been
1

extensively explored for different applications.14-22 Moreover, it is accepted that synthetic
glycopolymers mimic functions of naturally occurring polysaccharides23-24 and were
employed for binding cell-surface receptors.25 The strength and selectivity of binding
interactions between multivalently displayed carbohydrates and targets are likely to
depend on the density and relative spatial arrangement of the carbohydrate residues of
glycopolymers.25 Recently, the potential utility of glycopolymers in bio- and
immunochemical assay, as biocapture reagents and for microarray applications has been
demonstrated by the addition of functional anchor groups either as a pendant to the
polymer backbone or at the chain end. Particularly, the chain-end groups of the polymer
are the focus for bio-functionalization, as they allow for a direct one-to-one attachment2627

and also facilitate site specific16 and oriental immobilization on solid surface.28 This

molecular recognition is especially exploited on surfaces for the development of
biosensors, chip-based bioassay, or cell-adhesion studies29 as they mimic the three
dimensional display of glycans on the cell surface.

2

Figure 1. Cell Surface Carbohydrates: protein–carbohydrate interactions at the cell
surface mediating biological processes.

1.2 Chain-end functionalized glycopolymers
Glycopolymers carrying pendant sugar moieties are either synthesized by direct
polymerization of carbohydrate-containing monomers with protection group or without
protection group, or by the post polymerization glyco-conjugation of synthetic
polymers.30 The polymerization can be carried out by a range of polymerization
techniques. This includes: free-radical polymerization (FRP),31 living anionic
polymerization,32 ring-opening polymerization (ROP),33 ring opening metathesis
polymerization (ROMP),34 cyanoxyl mediated free-radical polymerization (CMFRP),35
3

and controlled/living free-radical polymerization (CLRP) which, encompasses nitroxide
mediated controlled free-radical polymerization (NMP),36 atom transfer radical
polymerization (ATRP),37 reversible addition-fragmentation chain transfer (RAFT)38
polymerization. During the past decade, various glycopolymers with diverse chain-end
functional groups like aldehyde, azide, biotin, N-hydroxysuccinamide, malimide,
pyridine disulfide, and O-cyanate have been synthesized for various applications.
ROMP,39-41 CMFRP,28,

42-43

ATRP,44-47 and RAFT48-52 have been employed for the

synthesis of chain-end functionalized glycopolymers. The syntheses and applications of
the above stated chain-end functionalized glycopolymers was summarized as in Table 1.

Table 1. Chain-end functionalized glycopolymers and their syntheses and biomedical
applications
Chain End

Carbohydrate

Synthesis

Application

Fluorescein

3,6-O-disufo-Gal

ROMP and post

L-selectin binding on

conjugation

cell surface

ROMP and post

Surface immobilization

40

Surface Immobilization

41

COOH

3,6-O-disufo-Gal

Reference
39

conjugation
Biotin

Chondrotin Sulfate

ROMP and post
conjugation

Biotin

Lact

CMFRP

Surface immobilization

42

Biotin,

Lact, O-sufo-Lact

CMFRP

Protein modification

43

COOH,
NH2,
Hydrazide

4

O-Cyanate

Lact.

CMFRP

Surface immobilization

44

Microarray
Azide

Glc

ATRP

Protein modification

45

Biotin

GlcNAc

ATRP

Surace immobilization

46

Malimide

Man

ATRP

Protein modification

47

Pyridine

GlcNAc

ATRP

Protein modification

48

Biotin

Gal

RAFT

Biotin

Glc, Lact

RAFT and post

disulfide
49
Surface immobilization

50

Microarray

51

conjugation
Alkyne

GalNAc

RAFT
and post conjugation

Biotin

GlcNAc, Man

RAFT

Surface immobilization

52

Biotin

Glc, Gal,

RAFT

Microarray

53

Man,Fuc,Rham, Xyl,

and post conjugation

Lact,6α-mannobiose
Panose,
GlcNAc, GalNAc, Nacetyllactosamine,
Antigen H,
SialylLacNAc, Lacto-Nfucopentanose II, Sialyl
Lewis X

The two significant features of these chain-end functionalized glycopolymer are
multivalency, which aids for high affinity and specificity for bimolecular recognition and
5

chain-end functional group that facilitates oriental immobilization of glycopolymer on to
solid surfaces to mimics cell surface carbohydrates. These glycopolymers were
covalently attached to, proteins, viruses, nucleic acid, nanoparticles, silica gel beads and
glass slides by chain-end functional group for protein modification and capturing
applications (Fig 2). Amongst all applications summarized, capturing of carbohydrate
binding protein by glycanarray technique is widely used and exhibits high potential for
development as a high-throughput analytical tool for investigating biological processes
engaged with carbohydrates. To date, many applications were demonstrated by chain-end
functionalized glycopolymers with model proteins like lectins to exhibit their potential as
an analytical tool for studying biological processes. Recent advances in living radical
polymerization have provided methods to build chain-end functionalized glycopolymers
with a whole range of biological recognition abilities.

Figure 2. Biomedical applications of chain-end functionalized glycopolymers.
6

1.3 Glycanarray
Microarray techniques have been developed as an analytical tool for studying
biological processes. DNA microarrays were first to be developed for analyzing mutation
of genes, studying changes in the gene expression patterns in disease conditions and
tracking the activities of genes at several times,54-57 later protein microarrays have been
developed as a high-throughput tool to study protein-protein interactions and to study
protein expressions in normal and diseased states.58-62 At first carbohydrate microarrays
have been developed to study the interactions between carbohydrates and carbohydrate
binding molecules like proteins,63-64 antibodies,65 pathogens66 etc,. Unlike DNA and
protein microarray development of carbohydrate microarrays courses more challenges
like sugars must be displayed at the reducing end for being recognized by the
carbohydrate binding molecules, the isolation and synthesis of carbohydrates are very
challenging and moreover the interactions between carbohydrates and proteins is stronger
and specific when the carbohydrates are present in a multivalent component (cluster
effect). Initial microarrays were developed with monovalent carbohydrates or the
oligosaccharides immobilized direly with the help of several linkers or functionalization
of

carbohydrates.63-66

Later

several

multivalent

carbohydrate

molecules

like

glycodendrimers, glycopolymers, glycoliposomes, neoglycoproteins, glyconanoparticles
etc were developed to achieve more specific and strong binding of proteins to
carbohydrate microarrays. It is understood that not only the multivalency of the
carbohydrates effect the binding specificity also the density and orientation of the
carbohydrates present on the solid surface effects the interactions significantly i.e. the
tight binding of proteins to carbohydrates on the array surface depends on multivalency
7

of carbohydrates with appropriate spacing and orientation of carbohydrates on the
surface.

1.4 Surface Plasmon Resonance
Surface Plasmon resonance (SPR) imaging is a surface sensitive optical technique that
is used for monitoring label free bio-molecular interactions in liquids.66-67 It has several
applications in the field of life sciences, electrochemistry, chemical vapor detection and
food and environmental safety. Especially in the field of life sciences SPR is applied to
determine the bio-molecular interactions and also to determine the association and
dissociation kinetics between bio-molecules like protein-protein,68-69 DNA-protein,70-72
DNA-DNA,73-74 antigen-antibody,75-76 protein-carbohydrate77-79 etc. Surface Plasmon
Resonance is a phenomenon that occurs when polarized light hits a metal film at the
interface of media with different refractive indices, in which light is focused onto a metal
film through a glass prism and the subsequent reflection is detected (Fig 3). Briefly, the
ligand is immobilized onto a gold chip and the analyte is passed over the ligand with
continues flow. As the analyte binds the ligand, the addition of mass on the surface
results in an increase in the refractive index and shift of angle from I to II (Fig 3). This
change in the refractive index is measured in real time and plotted as response units
versus time as sensorgram (Fig 3). SPR technique have several advantages like flexible to
use with several bio-molecules, requires no radioactive or fluorescent labeled samples,
very minute amount of sample required and also can study the molecular interactions in
real-time. SPR also have some limitations like nonspecific interactions between sensor

8

surface and sample, background refractive index variations due to different buffers used
in running buffer sample, sample temperature etc.80

Figure 3: Surface Plasmon Resonance: Change in the refractive index with addition of
mass onto the sensor chip, and shift of angle from I to II (lower left) plotted in real time
as sensorgram (lower right). Cited from Nature Reviews Drug Discovery, 1,515-528

9
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CHAPTER II

ORIENTATED GLYCO-MACROLIGAND FORMATION BASED ON
SITE-SPECIFIC IMMOBILIZATION OF O-CYANATE CHAIN-END
FUNCTIONALIZED GLYCOPOLYMER

2.1 Introduction
Glycopolymers as a multivalent clustering of carbohydrate derivates have proven to be
an effective tool in the study of carbohydrate-based cellular processes and show great
potential in biomedical applications like glycomics, biotechnology, biosensors, and
medicine. For example, glycopolymers have been explored for the development of
therapeutic agents,1 in bio and immunochemical assays,2 and as biocapture reagents3
applications. It has been found that the shape and size of glycopolymers4 as well as the
density and relative positioning of their glycan appendages5 turned out to be of high
importance regarding their effectiveness in bio-interactions. Therefore, a large variety of
various glyco-homo- and (block) copolymers, linear or branched, are reported realizing
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high control over the molar mass and the structure of the products.6 Furthermore, surfacebound multivalent glycan ligands were shown to exhibit higher avidity to protein
receptors compared to immobilized monomeric glycans.7 We first reported a biotin chainend functionalized glycopolymer for oriented glyco-surface engineering based on specific
non-covalent interactions.8-11 Since then, several groups had demonstrated the potential of
biotin chain-end functionalized glycopolymers for bioconjugation applications.12-16
Chain end functionalized glycopolymers were synthesized by the following techniques.

2.1.1 Synthesis of chain-end functionalized glycopolymer via ROMP
ROMP using a ruthenium-catalyst was frequently employed to synthesize
glycopolymers in the early 1990s. ROMP allows glycomonomers to be polymerized in a
controlled/living fashion, which will then enable the synthesis of block copolymers. The
catalysts used in ROMP are tolerant to many functional groups, thus permits the synthesis
with unprotected glycomonomer. In addition, the metal alkylidene catalysts could
potentially allow the preparation of specifically end-labeled compounds used for
detection in biological systems. Kiessling and co-workers first employed ROMP
technique for synthesis of bifunctionalized glycopolymer containing an enol ether at one
end and a masked carboxylic acid at the other end to which a fluorescein derivative was
conjugated.17 Recently, Linda C. Hsieh-Wilson et al. reported a synthesis of biotin chainend functionalized glycopolymers that mimic the native-like, multivalent architecture
found on chondroitin sulfate (CS) proteoglycans via ROMP.18 Overall, ROMP combined
with post-polymerization modification method provided the chain-end functionalized
glycopolymers. Although this method often requires an excess of substrate as well as
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some purification, it can still be useful. However, one may also argue that the toxic heavy
metals used in ROMP could potentially contaminate the final polymers; hence the
removal of these catalysts has to be scrutinized if the products are to be used in
biomedical applications.19

2.1.2 Synthesis of chain end functionalized glycopolymer via ATRP
ATRP is a control radical polymerization technique that has been widely
employed to prepare glycopolymers.20 With this technique, glycopolymers of predictable
molecular weights, narrow molecular weight distribution furthermore wide range of
functional groups were synthesized. M. G. Finn co workers employed the Cu I –catalyzed
ATRP and azide-alkyne cycloaddition reactions together for the synthesis of chain-end
functionalized glycopolymers and their attachment to a suitably modified viral protein
scaffold.21 Later, Geng et al. synthesized malimide chain-end functionalized
glycopolymer by combining ATRP and Huisgen [2+3] cycloaddition.22 In this study,
bovine serum albumin (BSA) was employed as a single thiol-containing model protein to
test the conjugation between thiol and malimide. A fluorescent tag rhodamine B dye was
introduced into polymer back bone to improve the characterization of polymer protein
conjugation and also for monitoring of their in vitro studies.
ATRP technique was also employed by Maynard and coworkers to synthesize a
biotin chain-end functionalized glycopolymer with N-acetyl-D-glucoamines as pendent
carbohydrates.23 They synthesized both protected and deprotected glycomonomers and
subjected them to

polymerization, interestingly, by both

ways

well-defined

glycopolymers with narrow polydispersity were achieved. Also different molecular
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weight polymers by altering the initial monomer-to-initiator ratios ([M]o/ [I]o) were
synthesized and the molecular weights (Mn) and polydispersity were determined by gel
permeation chromatography. The same group later synthesized a pyridyl disulfide chainend functionalized glycopolymer with the same N-acetyl-D-glucoamines as pendent
carbohydrate.24
Overall, ATRP represents an excellent avenue to controlled polymerization of
glycomonomers. The advantage of ATRP is the lower polymerization temperature. The
temperature during polymerization is particularly crucial as glycopolymers and their
monomers are usually unstable at temperatures higher than 120oC.25 A concern is the use
of toxic Cu ions to control the polymerization, which demands the thorough purification
of the glycopolymer if it is for biomedical application.

2.1.3 Synthesis of chain end functionalized glycopolymer via RAFT
The RAFT polymerization is carried out with thiocarbonylthio compounds (of the
general formula Z-C(dS)-SR, known as RAFT agents), which reversibly react with
growing radicals via chain transfer reactions. Consequently, chains undergo successive
active/dormant cycles that minimize radical termination processes and lead to a
simultaneous growth of all chains. The obtained polymer chains are characterized by the
presence of R and Z groups from the RAFT agents at their α- and ω-ends, respectively.
Then, the modification of the structure of the RAFT agent, that is, the R and Z groups,
appears as a highly powerful means for introducing a molecule of interest at polymer
chain ends. Therefore, RAFT is one of the promising techniques employed for the
synthesis of glycopolymers with chain-end functional groups. Ravin Narain et al.
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synthesized a series of glycopolymers using two different glycomonomers by RAFT
technique;

further

these

glycopolymers

were

evaluated

for

synthesis

of

glyconanoparicles.26 Charreyre et al. reported a synthesis of biotin chain-end
functionalized glycopolymer - poly(NAM-co-GalAm) via RAFT technique using biotinCTA.27
Direct polymerization of sugar-containing monomers has been proven to be
successful; modification of preformed polymers using saccharide-containing reagents
offers an alternative synthetic route. Betrozzi et al. have synthesized an orthogonally end
functionalized glycopolymer via RAFT and post-functionalization with saccharides.28
They synthesized mucin mimetic glycopolymer, with one end terminal bearing a surface
attachment element and the other end set for conjugation of a reporter group.
Using RAFT technique, the same group later reported a synthesis of biotinterminal poly(acryloyl hydrazide) (PAH) scaffold which could be conjugated to a range
of reducing sugars from simple mono- and disaccharides to highly complex human milk
and blood oligosaccharides.29
Overall, RAFT polymerization is a popular route for synthesizing glycopolymers.
Reaction temperatures used in RAFT polymerization are usually between 60 to 70oC, but
also the synthesis of polymers at room temperature is possible. The robustness of this
polymerization technique is reflected by the number of publications reporting the
synthesis of glyopolymers in past decade by RAFT technique. Comparing to direct
polymerization, the post-functionalization approach was demonstrated to be a convenient
to produce libraries of glycopolymers with the same macromolecular architecture by
attaching different sugar moieties to pre-formed polymer scaffolds. The drawback of the
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post-functionalization is the unsure reaction yield of saccharide modification, which
might lead to uncontrolled glycopolymers with different saccharide units in the polymer
and low reproducibility as well.

2.1.4 Synthesis of chain end functionalized glycopolymer via CMFRP
CMFRP of unprotected glycomonomers can be conducted in aqueous solution, is
tolerant of a broad range of functional groups including -OH, -NH2, -COOH, and SO3moieties, and can yield glycopolymers with low polydispersity (PDI < 1.5). CMFRP is a
straightforward approach to synthesize chain-end functionalized glycopolymers using
functionalized arylamine initiators.
In this study we designed a facile synthesis of amine and carboxylic acid chainend functionalized glycopolymers via cyanoxyl mediated free radical polymerization
(CMFRP) by using amine and carboxylic acid functionalized aryl amine as initiator,
respectively.11 Interestingly, all these glycopolymers have an O-cyanate group at the other
chain-end, which might serves as a reactive chain-end group, but not being investigated
yet. During the past decades, O-cyanate-based isourea bond formation has been proven to
be a very useful tool in bioconjugate chemistry such as protein and antibody
immobilization.30-32 Therefore, we envisioned that the chain-end O-cyanate group of the
glycopolymer provides an anchor for site-specific and covalent immobilization of the
glycopolymer onto an amine surface via isourea bond formation and thereby facilitates an
oriented glyco-macroligand formation (Fig 1). Herein, we report the oriented glycomarcroligand formation and its glyco-affinity capturing and glycoarray application by
21

combining O-cyanate chain-end functionalized glycopolymer with commercially
available amine-modified silica gel and glass slide via isourea bond formation,
respectively. In this study, the multivalent lactose units serve as model affinity
carbohydrate ligands for lectins33 and cells surface carbohydrate such as GM3 for
carbohydrate-carbohydrate interaction-based cell – cell intereactions.34

Figure 1. Chemical structure of O-cyanate chain-end functionalized glycopolymer and
its oriented glyco-macroligand formation via isourea bond formation.

2.2 Experimental
2.2.1 Materials and methods
All solvents and reagents were purchased from commercial sources and were used as
received, unless otherwise noted. Deionized water with a resistivity of 18 Mcm was
used as a solvent in all polymerization reactions. Glycomonomer, 2-N-Acryoylaminoethoxyl 4-O-(β-D-galatopyranosyl)-β-D-glucopyranoside (3) was synthesized as
described in reported method.11 Thin-layer chromatography (TLC) was performed on
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Whatman silica gel aluminum backed plates of 250 µm thickness on which spots were
visualized with UV light or by charring the plate after dipping in 15% H 2SO4 in
methanol. Dialysis was performed on cellulose membrane with a molecular weight cutoff
of 3K with water as solvent. 1H spectra were recorded at room temperature with a Varian
INOVA 300 MHz spectrometer. In all cases, the sample concentration was 10 mg/mL,
and the appropriate deuterated solvent was used as an internal standard. UV-vis
absorbance spectra were recorded on Varian Bio50 UV-vis spectrometer. IR spectra were
measured on Broker FT-IR spectrometer. Fluorescence spectra were measured on Hitachi
F-7000 Fluorescence Spectrophotometer.

2.2.2 Synthesis of O-cyanate chain-end functionalized glycopolymer 4
In a three-necked flask, dissolved 4-chloroaniline (21.6 mg, 1.69 x 10-4 mol), sodium
nitrite (14.1 mg, 2.04 x 10-6 mol) in a mixture of 2 mL water and THF (1:1, v/v). To the
above mixture, added HBF4 (66 mg, 7.51 x 10-4 mol) and allowed it to react for 30 min at
0°C under Ar atmosphere. Following this, a degassed mixture of 2-N-Acryoylaminoethoxyl 4-O-(β-D-galatopyranosyl)-β-D-glucopyranoside 3 (186 mg, 2.65 x 10-5
mol), acryl amide (210 mg, 2.65 x 10-4 mol) and NaOCN (55.2 mg, 8.49 x 10-4 mol)
dissolved in 1 mL of water was added into the flask containing diazonium salt. The
reaction solution was thus heated at 65°C for 16 hrs, and then was filtered to remove any
precipitates. The resultant mixture is separated of any inorganic salts and impurities by
dialysis against deionized water for 2 days at room temperature to afford glycopolymer 4
(248 mg). The conversion yield was about 60%, which was determined by weight for the
resultant glycopolymer.
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2.2.3 Quantification of carbohydrate in glycopolymer (Phenol-Sulfuric Acid Assay)
Phenol-sulfuric acid assay was used to quantify the lactose molecules attached on the
glycopolymer 4. To 0.5 mL of sugar solution, added 0.5 mL of 5% aq. phenol solution,
2.5 mL of H2SO4 (96%) and vortexed the mixture. Prepared the blank with distilled water
replacing the sugar solution. Allowed above solutions to stand for 30 minutes at room
temperature and measured the absorbance at 490 nm. A calibration curve of sugar (βlactose) concentration versus absorbance (A) was plotted and the presence of sugar on the
polymer was detected by measuring the absorbance of glycopolymer samples (0.1 moles,
0.5 moles and 1 mole).

2.2.4 Immobilization of glycopolymer 4 onto amine-modified silica gel through isourea
bond formation and its affinity lectin capture
Glycopolymer 4 (8.5 mg, 1.21 x 10-3 mol) was added to 200 mg of amine functionalized
silica gel beads (Sigma) in 2 mL of NaHCO3 buffer (pH 8.3). The mixture was shaked
for 4 hrs at room temperature and then was packed into a column. The column was
washed with NaHCO3 buffer (pH 8.3) followed by PBS buffer (pH 7.4). Lectin-FITC
solution (Arachis hypogae, FITC-Labeled, 0.5 mg, 4.16 x 10-9 mol) in PBS buffer (pH
7.4) (1 mL) was loaded onto the column. The drained solutions were collected and
preserved for further analysis. The column was then washed with PBS buffer (pH 7.4) to
remove the unbounded lectin. Finally, the captured lectin was released by eluting with
free lactose (1 M) and was analyzed by SDS-PAGE and quantified by fluorescence
spectroscopy.
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2.2.5 Oriented glycopolymer glycoarray via O-cyanate-based isourea bond formation
Glycopolymer microarrays were fabricated by microcontact stamping with MicroCaster
Arrayer (Whatman). The MicroCaster array tool (spot size 500 µm diameter) was inked
with a solution of glycopolymer (4, 1 mg/mL, 1.4 x 10-7 moles) in NaHCO3 buffer (pH,
8.3). The MicroCaster tool was pressed onto amine functionalized glass slide (Xenopore,
Co) for 10 min. The glass slide was incubated in a humidifier chamber for 4 hrs and then
washed for 1 hr (3 times) with respective buffers followed by washing with PBS
containing 0.2% tween 20 (PBST) to minimize nonspecific binding of proteins to the
surface. Then the glass slides were incubated with lectin-FITC (Arachis hypogae, FITCLabeled, Sigma) solution (0.2 mg/mL) in PBST (pH 7.4) buffer for 3 hrs followed by
extensive washing with PBST buffer for 1 hr and subjected to fluorescent imaging by
using Typhoon 9410 Variable Model Imager (Amersham Biosciences, USA). A control
was prepared by incubating the glycopolymer printed glass slide with lactose (200 mM,
PBS (pH 7.4)) pre-incubated lectin-FITC.

2.3 Results and discussion
2.3.1 One-pot synthesis and characterization of O-cyanate chain-end functionalized
glycopolymer
The synthesis of glycopolymer with chain-end functionalized still poses significant
challenges, including a requirement for serial protection/deprotection steps or further
polymer derivatization after initial synthesis. In the present study, the O-cyanate chainend functionalized glycopolymers were synthesized via our previously developed
cyanoxyl free radical mediated copolymerization scheme in one-pot fashion (Scheme
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1).18 Briefly, 4-chloroanaline 1 was used as initiator for the copolymerization of
acrylaminoethyl lactoside 3 and acrylamide. Specifically, cyanoxyl radicals were
generated by an electron-transfer reaction between cyanate anions from a sodium cyanate
aqueous solution and aryl-diazonium salts prepared in situ through a diazotization
reaction of arylamine in water. In addition to cyanoxyl persistent radicals, aryl-type
active radicals were simultaneously produced, and only the latter species was capable of
initiating chain growth. A series of O-cyanate chain-end functionalized glycopolymers of
varying sugar density were prepared by altering glycomonomer (GM) and acrylamide
(AA) in good conversion yield (60-70%) and low polydispersity (1.1 < Mw/Mn < 1.6) as
described previously.11

Scheme 1. Synthesis of O-cyanate chain-end functionalized glycopolymer.
The chain-end O-cyanate functional group of glycopolymer 4 was confirmed by IR
spectrum, in which O-cyanate absorption was observed at 2157 cm-1 (Fig 2A). It is also
noteworthy that the O-cyanate group could be converted to a hydroxyl group by
treatment with pyridine in water.35 Therefore, the disappearing of O-cyanate absorption
band at 2157 cm-1 after pyridine treatment of glycopolymer 4 (to 5) confirmed the
existing of O-cyanate chain-end group and complete hydrolysis of the O-cyanate group
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(Fig 2B). By comparison of 1H NMR of 4 and 5 (Fig 3), there was no apperent polymer
structural change observed during the hydrolysis reaction.

Figure 2. FT-IR spectra of O-cyanate chain terminated glycopolymer 4 (A) and hydroxy
chain terminated glycopolymer 5 (B).
1

H NMR spectrum was used to calculate of polymer component content and

length by using phenyl group at the polymer other chain terminal. As shown in 1H NMR
spectrum of glycopolymer 4 (Fig 3A), comparison of the integrated signal from the
phenyl protons (7.04 ppm, H2',6' and 7.22 ppm, H3',5') with that due to the anomeric
protons of lactose (4.36 ppm, H1'-Lact and 4.43 ppm, H1-Lact), as well as that of the polymer
backbone methine (2.10 ppm, CH) and methylene (1.55 ppm CH2), indicated an average
glycopolymer composition of 10 lactose and 70 acrylamide units. The molecular weight
(Mn) was about 7,000 as determined by 1H NMR. Furthermore, the grafted carbohydrate
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on the glycopolymer 4 was quantified via the phenol-sulfuric acid method.37 Briefly,
concentrated H2SO4 was added directly into a solution of phenol and glycopolymer 4.
The mixture was then vortexed, and allowed to stand for 30 min at room temperature.
The optical density was then recorded at 490 nm. As a result, there was an average of 8
lactose units per polymer (Fig 4) , which is close to that determined by the 1H NMR
above.

Figure 3. 1H NMR spectra of O-cyanate chain terminated glycopolymer 4 (A) and
hydroxyl chain terminated glycopolymer 5 (B) in D2O.

28

Figure 4. a.UV Absorbance spectrum of sugar-phenol conjugate b. A calibration curve
of sugar (β-lactose) concentration versus absorbance (A)

2.3.2 Immobilization of glycopolymer onto silica gel via O-cyanate-based isourea bond
formation and its affinity chromatography application
Silica gel has been widely used as small, rigid particle for high performance affinity
chromatography since it is capable of withstanding the high flow rates and /or pressures.
The introduction of functional groups on a silica surface to yield modified silica gel has
received great attention for the development of functionalized silica gel for
chromatography application.37 In particular; methods such as covalent grafting of
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polymers or coating with hydrophilic polymers have succeeded in passivating the silica
surface and conferring specificity. Recently, silica materials containing covalently bound
sugars have been explored for boron removal38 and isolation and purification of lectins3940

applications. In the present study, oriented immobilization of multivalent carbohydrates

onto silica gel surface was investigated for efficient and inexpensive isolation and
purification of carbohydrate-binding proteins (Fig 5). Briefly, O-cyanate end-terminated
glycopolymer 4 was immobilized onto the surface of silica gel by incubation of 4 with 3aminopropyl-functionalized silica gel (Sigma) in sodium bicarbonate (pH 8.3) buffer
solution at room temperature for 2 hrs and followed by thoroughly washing with di water
three times. Control experiment with the hydroxyl chain-end functionalized
glycopolymer 5 was conducted in the same scale. The amount of glycoplymer
immobilized on the silica gel was determined by phenol-sulfuric acid method 37. Briefly,
phenol solution was added to a solution of glycopolymer-silica gel, and mixed. Then
concentrated H2SO4 was added directly into the solution. The mixture was then vortexed,
and allowed to stand for 30 min at room temperature and finally centrifuged. The optical
density of the supernatant was then recorded at 490 nm. As a result, there was an average
of 276 nmol of O-cyanate chain terminated glycoplymer 4 per gram of silica gel, while
there was no detectable glycopolymer determined with hydroxyl chain terminated
glycopolymer 5 treated silica gel. This result indicated specific immobilization of
glycopolymer through isourea bond formation.
Once the glycopolymer-silica gel (GP-SG) was synthesized, its ability to capture
lectin was evaluated as an adequate methodology to characterize and determine their
potential applicability as a chromatographic support. The characterization was carried out
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by packing the glycopolymer-silica gel in a column followed by saturating the column
with a β-galactose-specific lectin (Arachis hypogae, FITC-Labeled, 0.5 mg, 4.16 x 10-9
mol, Sigma) in PBS (pH 7.4) buffer solution and followed by washing with PBS (pH 7.4)
buffer to remove the unbounded lectin (Fig. 5A). Lectin capturing was confirmed with
visualization of FITC-labeled lectin on the glycopolymer silica gel column under UV
lamp (Fig 5B1), while raw silica gel showed little non-specific capturing of the lectin
(Fig 5B2). Further, there was no capturing was observed for the non-specific lectin
(glucose/mannose-specific Concavalin A) on the glycopolymer silica gel (data not
shown). Next, eluting the column with 1 M free lactose in PBS (pH 7.4) buffer released
the specific captured lectin on the glycopolymer-silica gel (Fig 5C1). A similar protocol
was followed with raw silica that was thus established as a control assay (Fig 5C2). The
lectin-capturing capacity was 13.9 nmol of lectin per mg of silica gel modified with
glycopolymer, while 2.9 nmol of lectin per mg of raw silica gel as non-specific binding
as determined by fluorescence intensity analysis. Finally, the specific captured lectin was
confirmed with SDS-PAGE (Fig 6). Specifically, the captured lectin on glycopolymer
modified silica gel was confirmed on protein staining gel (Gel A, lane 4) and silver
staining gel (Gel B, lane 4), while no non-specific lectin (glucose/mannose-specific
Concavalin A) on the glycopolymer silica gel was observed on protein staining gel (Gel
A, lane 5) and silver staining gel (Gel B, lane 5). These results demonstrated the
successful oriented glyco-marcroligand formation and its carbohydrate-binding protein
purification and identification capacity.
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Figure 5. Illustration of glycopolymer immobilization onto silica gel and its lectin
capturing onto glycopolymer-silica gel (A), Lectin capturing onto glycopolymer-silica gel
column (B1) and raw silica gel (B2), after elution with free lactose (C1 and C2).

Figure 6. SDS-PAGE identification of unbound and released lectins from silica gel
beads (A: silver staining; B: Protein staining): M: MW marker, 1: lectin alone, 2:
unbound lectin from glycopolymer-silica gel, 3: unbound lectin from control raw silica
gel, 4: captured lectin eluted from glycopolymer-silica gel, 5: non-specific lectin eluted
from glycopolymer-silica gel.
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2.3.3 Oriented glycopolymer glycoarray via O-cyanate-based isourea bond formation
Surface-bound multivalent glycan ligands showed higher avidity to protein receptors
compared to immobilized monomeric glycans.14 Inspired by this example, we sought to
develop oriented glycopolymer array that spatially position the pendant glycans similarly
to natural glycoproteins. Specifically, integration of such constructs into arrays may
create a more physiologically authentic platform for probing glycan binding proteins. In
the present study, glycopolymer microarray (spot size 500 µm diameter) was fabricated
by microcontact stamping glycopolymer 4 onto amine functionalized glass slide
(Xenopore, Co) in NaHCO3 buffer (pH, 8.3) (Fig 7). The glass slide was incubated in a
humidifier chamber for 4 hrs and then washed for 1 hr (3 times) with respective buffers
followed by washing with PBS containing 0.2% tween 20 (PBST) to minimize
nonspecific binding of proteins onto the surface. Then the glass slides were incubated
with lectin-FITC (Arachis hypogae, FITC-Labeled, Sigma) solution in PBST buffer for 3
hrs followed by extensive washing with PBST buffer for 1 hr and finally subjected to
fluorescent imaging. A control was prepared by incubating the glycopolymer arrayed
glass slide with lactose (200 mM) pre-incubated lectin-FITC instead of free lectin.
Fluorescence microscopy analysis of the surfaces revealed specific binding of lectin only
to the immobilized glycopolymer (Fig 7B). The lectin binding to arrayed glycopolymer
was inhibited in the presence of free lactose (Fig 7C), further confirming the specific
lectin binding to the glycopolymer. Moreover, glycopolymer array with different
concentration of glycopolymer showed concentration-dependent lectin binding to
glycopolymer (Fig 7D). These observations indicated that arrayed glycopolymers can
distinguish glycan-binding proteins based on their ligand specificity.
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Figure 7. Glycopolymer microarray for probing specific glycan–protein interactions (A),
fluorescent imaging of FITC-labeled lectin binding to microarrayed patterns of
glycopolymers (B), control with lactose pre-incubated lectin-FITC (C) and with different
concentration of glycopolymer in array (a: 0.001 mg/mL, b: 0.1 mg/mL and c: 0.5
mg/mL) (D). Bar size: 500µm.

2.4 Conclusions
An

oriented

glyco-marcroligand

formation

based

on

O-cyanate

chain-end

functionalized glycopolymer with commercially available amine modified silica gel and
glass slide via isourea bond formation was demonstrated, respectively. The O-cyanate
chain-end functionalized glycopolymer was synthesized via one-pot cyanoxyl mediated
free radical polymerization. It is notable that the polymerization can be performed under
aqueous condition and is tolerant of a wide range of monomer functionalities, including OH, -COOH, -NH2 and -OSO3- groups.18 Therefore, there is no protection and
deprotection needed and thus is a straightforward approach.
Notably, multivalent lactose units serve as model ligands but can be changed to any
specific carbohydrates for specific lectins or cells. The chain-end O-cyanate group of the
polymer provides an anchor for site-specific and covalent immobilization of the
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glycopolymer onto any amine surface via isourea bond formation in mild condition,
which can be used for biosensor and glycoarray applications. In addition, the chain-end
functionalizable glycopolymer can be used for polymer-protein conjugation as well.
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CHAPTER III

GLYCO-MACROLIGAND MICROARRAY WITH CONTROLLED
ORIENTATION AND GLYCAN DENSITY

3.1 Introduction
Glycan microarray has become powerful high-throughput tool for examining binding
interactions of carbohydrates with lectins, antibodies, cells, and viruses.1 Recently, it has
been applied to clinical antibody detection and profiling,2 vaccine development,3
biomarker discovery,4 and drug screening5 applications. Nevertheless, they are still not
perfect for clinical applications and novel microarray designs are much needed to
improve the performance of this technology. Two critical limitations prevent wide and
potential applications of the glycan microarray technology. First, the detection is limited
by restricted epitopes available for microarray fabrication from both synthesis and
isolation from nature sources. Second, the features of glycan presentation on the
microarray surface such as density and orientation of glycans have substantial effect on
protein recognition related to both affinity and specificity. Conventional glycan
microarrays were made by directly immobilizing glycans onto microarray surfaces by
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either physical absorption or covalent conjugation, which directly mimics the multivalent
display of carbohydrate epitopes on the cell surface. However, this two dimensional (2D)
surface immobilization chemistry usually results in low signal intensity and substantial
non-specific binding of target proteins due to an insufficient number of accessible
glycans and the presence of surface-protein interactions. To overcome this limitation,
recently, glycan density on the array surface has been recognized as very important
feature of carbohydrate recognition and thus has been investigated extensively.6-12
A general strategy for modulating glycan density is to vary the concentration of
the monovalent glycans in the printing solution that is being spotted onto a microarray
slide. However, this approach is not generating variations in density in the molecular
level and often yields inconsistent results. Particularly, often variations in density
gradient over the spot are seen when the surface is not saturated with diluted printing
solution. Alternatively, new strategies have been developed, in which multivalent
glycoconjugates with varying density were first synthesized, and then printed onto a solid
support to generate a microarray of multivalent glycans in different densities.
Another key feature of the glycan presentation in glycan microarray is the glycan
orientation. Cell surface glycans are spatially displayed such as glycoprotein scaffolds
with three-dimensional (3D) geometries. However, conventional glycan arrays present
glycans on a 2D substrate and thus have limited activity. Early study confirmed that
surface-bound multivalent glycan ligands show higher avidity to protein receptors
compared to immobilized monomeric glycans.13
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3.1.1 Glycodendrimer-Based Glycoarray
Pieters and coworkers have studied the binging of lectins to carbohydrates with
respect to the effect of multivalency of carbohydrate moieties and the inter-binding-site
distances of lectins14-15 They primarily started with synthesized mannose based
glycodendrimers and tested against two different lectins ConA and WGA14 later enlarged
their work by synthesizing five different glycodendrimers to evaluate a series of lectins. 15
The same phenomenon was observed with the other eight lectins that were tested against
five different glycodendrimers, lectins with increase in inter–binding-site distance
displayed decrease in the multivalency effect.
Wang and coworkers employed a different approach for construction of
glycodendrimer microarray in their recent studies16 by initially preparing a three
dimensional dendrimeric platform followed by linking the carbohydrate to the dendrimers
surface. The cluster effect was tested by spotting oligosaccharides dendrimers of all five
generation which were further incubated with lectin and observed that with increase in
the surface groups the fluorescent intensity also increase exhibiting the multivalency
effect.
Overall, glycodendrimers were successfully synthesized for microarray applications
and were qualified in the screening of carbohydrate-protein interactions through
carbohydrate microarrays.
These glycodendrimers microarrays not only explored the protein-carbohydrate
interactions but also reported how the multivalent carbohydrate display on the array
surface aids the protein binding to carbohydrates in the aspects of both sensitivity and
selectivity. From the reported glycodendrimers microarrays it is accepted that the
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multivalency of the carbohydrates is well controllable by dendrimers but the spacing and
orientation of the carbohydrates on the array surface are not yet organized to study their
effect on protein binding to carbohydrates.

3.1.2 Neo-Glycoprotein-Based Glycoarray
Gildersleeve et al have developed a method for varying both the structure and density
of the carbohydrates on the carbohydrate antigen microarray and evaluated the density
dependent binding effects for tumor- binding lectins, monoclonal antibodies and serum
antibodies.5 For this approach they have conjugated carbohydrate to carrier protein like
bovine serum albumin (BSA), in which the carrier protein served as both the multivalent
scafold and the linker for immobilization on to glass slides. Carbohydrates were
conjugated to free amine groups of BSA via reductive amination of oligosaccharides or
by coupling the oligosaccharides with carboxylic acid via activation with EDC/NHS. To
vary the density number of carbohydrates attached to the BSA were controlled.
Gildersleeve’s group17 synthesized several neo-glycoconjugated with variying
carbohydrate density. They have observed that selectivity of lectins for particular
carbohydrate over other carbohydrates declined at high density. Followed by this they
evaluated the density –dependent binding properties of a set of monoclonal antibodies
and determined that antibodies to the same carbohydrate antigen can recognize density in
significantly different ways. Also they have tested the density-dependent binding
properties of serum antibodies of 30 subjects, the results demonstrated that modulation of
antigen density can be used to reveal differences in antibody populations between
different subjects. Their results from the above study reveled that both structure and the
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density of the carbohydrates significantly affect the affinity and selectivity to
carbohydrate binding compounds. Gildersleeves et al proved that the density of the
carbohydrates on the surface are significant in studying in carbohydrate binding ligands.

3.1.3 Liposome-based glycoarray
Our group recently investigated the application of azide-reactive liposome for efficient
and chemically selective immobilization and microarray fabrication18. Azide reactive
liposomes were synthesized with DSPE-PEG2000-triphenylphosphine, phospholipids
(DSPE) and cholesterol rapid extrusion method. Azide reactive liposomes were
immobilized on azide functionalized glass slides and later subjected to and lectin binding
studies were conducted by incubating the liposome immobilized glass slide with lectin
PNA and observed the lectin binding to lactosylated liposome and no binding observed to
liposome with just anchor group.
Later this work was extended to study the glycolipid and protein interactions 19 by
incorporating natural and synthetic glycolipids into liposomes, and immobilizing them
onto an azide functionalized glass slide to test the binding affinities of lectins. These
microarrays mimic the presentation of carbohydrates on the cell surface and the binding
curves indicate that the liposomal microarrays with different glycolipids show specific
density dependent binding capacity and affinity as well.

3.1.4 Glycopolymer-Based Glycoarray
Glycopolymers carrying pendant sugar moieties are either synthesized by direct
polymerization of carbohydrate-containing monomers with protection group or without
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protection group, or by the post polymerization glyco-conjugation of synthetic
polymers.20 In recent years glycopolymers have been synthesized by several techniques
for various biomedical applications particularly glycopolymers with end functional group
have been synthesized excessively for microarray applications. Chain-end functionalized
glycopolymers demonstrated homogeneous immobilization of the glycopolymer via a
single terminal anchor to yield an oriented and density controlled displaying of
multivalent pendent carbohydrates.
Bertozzi’s group synthesized a duel end functionalized mucin like glycopolymer21
with a center mucin mimetic domain with N-actylgalactosemamine moieties, one
terminal alkyne group as surface attachement element and a second terminal outfitted for
conjugation of texas red as a fluorophore. By microcontact printing the alkyne terminal
glycopolymers were immobilized onto azide functionalized surface in presence of a
copper catalyst, which forms a stable triazol linkage to covalently immobilize the
glycopolymer. As the glycopolymer was also functionalized with fluorescent tag Texas
red on the other end the immobilization of polymer was confirmed by fluorescent
microscopy. Also the ligand specificity of glycans of the polymer was tested by
immobilizing non-fluorescent tag glycopolymer and testing the binding of Texas Red
tagged Helixpomatia agglutinin (Texas Red-HPA) that recognizes α-GalNAc, the
analysis of the surface by fluorescent microscopy revealed the specific binding of HPA
only to α-GalNAc confirming the specific binding of glycans. The same group later,
developed an approach synthesis of glycopolymers for microarray applications via
ligation of reducing sugars to backbones carrying hydrazide groups and end functional
group.22 They arrayed a group of biotinylated glycopolymers onto streptavidin-coated
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glass slides which were recognized by lectins specifically depending on their pendant
glycans.
Recently, Linda C. Hsieh-Wilson et al. synthesized a biotin end functionalized
glycopolymer that mimic chondroitin sulfate proteoglycans via ring-opening metathesis
polymerization technique23 which were employed for microarray and SPR applications.
Both sulfated CS-E and nonsulfated CS-C glycopolymers were immobilized onto
streptavidin coated glass slides by high-precision contact-printing robot which delivers a
nanoliter volmes of glycopolymer onto glass slides. Polymer immobilized glassslides
were tested for binding of specific monoclonal antibodies 2D11 and 2D5, which are
selective for CS-E and CS-C glycopolymers respectively. And they also studied the
binding of a growth factor, glial cell-derived neurotropic factors selective for sulfated
epitopes, which showed higher selectivity for CS-E compared to CS-C by both
microarray and SPR techniques.
Nevertheless, the density of the immobilized glycopolymer on the array surface is
still uncontrollable, and thus, the possibility to access the multivalent glycans in parallel
might be limited and thus does not facilitate maximum protein binding affinity and
specificity. In this study, we studied an oriented and density controlled glycopolymer
microarray formation based on end-point immobilization of glycopolymer combined with
molecular spacing technique. Briefly, O-cyanate chain-end functionalized glycopolymer
was pre-complexed with boronic acid ligands in different sizes and then immobilized
onto amine-functionalized glass slide via isourea bond formation at high pH value (pH
10.3 buffer). Once the immobilization is complete, the spacer boronic acid ligands were
released from the immobilized glycopolymers at a reduced pH value (pH 7.4 buffer)
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condition so as to afford the oriented and density controlled glycopolymer microarray
(Fig 1). This glyco-macroligand microarray platform will facilitate both affinity and
specificity of protein binding and thus will provide a versatile tool for profiling glycan
recognition for both basic biological research and practical applications.

Figure 1. Schematic illustration of orientation and density controlled glycopolymer
microarray formations based on end-point immobilization of glycopolymers that were
acompanied with boronic acid (BA) ligands in different sizes as temporory molecular
spacers followed by releasing the BA ligands from the immobilized glycopolymers.
Reaction conditions: i. R1-BA, NaHCO3 buffer (pH 10.3), ii. R2-BA, NaHCO3 buffer (pH
10.3), iii. R3-BA, NaHCO3 buffer (pH 10.3), iv. NaHCO3 buffer (pH 10.3), v. 1 mM
Glucose, PBS buffer (pH 7.4)

3.2 Experimental
3.2.1 Materials and Methods
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All solvents and reagents were purchased from commercial sources and were used as
received, unless otherwise noted. Lysozyme, bovine serum albumin, amino phenyl
boronic acid, FITC-PNA (Arachis hypogae) and alizarin red S were purchased from
Sigma. lectin FITC-RCAI (Ricinus communis) was purchased from EY Laboratories.
amine functionalized glass slides were purchased from Xenopore, Co.

3.2.2 Syntheses of O-cyanate chain-end functionalized glycopolymers
Glycopolymers were synthesized according to our previously reported method. 24
Briefly, in a three-necked flask, dissolved 4-chloroaniline (21.6 mg, 1.69 x 10-4 mol),
sodium nitrite (14.1 mg, 2.04 x 10-6 mol) in a mixture of 2 mL water and THF (1:1, v/v).
To the above mixture, added HBF4 (66 mg, 7.51 x 10-4 mol) and allowed it to react for
30 min at 0°C under Ar atmosphere. Following this, a degassed mixture of 2-N-Acryoylaminoethoxyl 4-O-(β-D-galatopyranosyl)-β-D-glucopyranoside

(186 mg, 2.65 x 10-5

mol), acryl amide (210 mg, 2.65 x 10-4 mol) and NaOCN (55.2 mg, 8.49 x 10-4 mol)
dissolved in 1 mL of water was added into the flask containing diazonium salt. The
reaction solution was thus heated at 65°C for 16 hrs, and then was filtered to remove any
precipitates. The resultant mixture is separated of any inorganic salts and impurities by
dialysis against deionized water for 2 days at room temperature to afford glycopolymer
(248 mg). The conversion yield was about 60%, which was determined by weight for the
resultant glycopolymer. Four kinds of glycopolymers with different ratios of pendant
glycan and molecular weights (1a, 1b, 1c and 1d) were obtained by using different ratios
of glycomonomer (GM) to acryl amide (AA) and were characterized by 1H NMR spectra
(Table 1 and Figure 2).
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3.2.3 Syntheses of boronic acid (BA) ligands
3.2.3.1 Synthesis of Lysozyme-BA: To 5 mL ice cold 0.05 M MES (pH 6), add 100 mg of
lysozyme (6.9 µmoles), 20 mg of aminophenyl boronic acid (APBA) (130 µmoles) and
10 mg of EDC with constant stirring. The reaction was allowed to take place for 2 hrs at
room temperature, then adjust the pH to 7 and let the reaction continue overnight at room
temperature. Separate the salts and the unreacted APBA by centrifugation in 10 kDa cutoff filter tube for 30 mins. The resultant lysozyme-BA conjugate was characterized by
SDS-PAGE and Alizarin Red S assay (ARS) assay (Fig. 5A).
3.2.3.2 Synthesis of BSA-BA: To 5 mL ice cold 0.05 M MES (pH 6), add 100 mg of
BSA (1.5 µmoles), 20 mg of APBA (130 µmoles) and 10 mg of EDC with constant
stirring. After 2 hrs, adjust the pH to 7 and let the reaction sit overnight at room
temperature. Separate the salts and the unreacted APBA by centrifugation in 10 kDa
cutoff filter tube for 30 mins. The resultant BSA-BA (BSA-BA) conjugate was
characterized by SDS-PAGE and ARS assay (Figgure 5B).

3.2.4 Glycopolymer microarray formation and lectin binding assay
MicroCaster microarray tool (Whatman, spot size 500 µm diameter) was inked with a
solution of glycopolymer (1a, 4.8 X 10-5 mM) in NaHCO3 buffer (pH 10.3), then was
pressed onto an amine functionalized glass slide (Xenopore, Co) at room temperature for
10 mins. The glass slide was then incubated in a humidifier chamber at room temperature
for 4 hrs and then washed with NaHCO3 buffer (pH 10.3) for 30 mins (3 times) to
removed un-reacted glycopolymer, then followed by washing with 0.2% PBST for 30
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min. The glass slides were then incubated with lectin-FITC (Arachis hypogae), FITCLabeled, Sigma, 0.2 mg, 1.61 X 10-9 moles) PBS containing 0.2% Tween 20 (PBST)
solution at room temperature for 3 hrs followed by extensive washing with PBST buffer
for 30 mins. Finally, the glass slide was subjected to fluorescence imaging and the
fluorescence intensity was recorded by using Typhoon 9410 Variable Model Imager
(Amersham Biosciences, USA). In the same condition, glycopolymer microarrays with
glycopolymer 1b, 1c, 1d were conducted, respectively.

3.2.5 Density controlled glycopolymer microarray formation and lectin binding assays
Glycopolymer (1b, 3 mg, 7.7 x 10-5 mmoles) was mixed with polyacrylamide-BA ligand
(3 mg, 1.5 x 10-4 mmoles) in 3 mL of 10.3 pH NaHCO3 buffer and was stirred at room
temperature for 4 hrs. MicroCaster microarray tool (Whatman, spot size 500 µm
diameter) was inked with the glycopolymer- boronic acidcomplex solution (1 mg/mL, 1:2
mol) and then was printed onto an amine functionalized glass slide in NaHCO3 buffer
(pH 10.3). The glass slide was then incubated in a humidifier chamber for 4 hrs and then
washed with NaHCO3 buffer (pH 10.3) 30 mins (3 times) to remove un-reacted
glycopolymer and boronic acid ligands. Detachment of boronic acid ligand from the
immobilized glycopolymer was performed by incubating the glass slide with 7.4 pH PBS
buffer for 30 mins and followed by 7.4 pH PBS buffer with 1 mM glucose for 10 mins.
Boronic acid ligands detached from the glycopolymer were confirmed by ARS assay (fig
7). The glass slide was washed with PBST buffer for 30 mins then incubated with lectinFITC (Arachis hypogae, FITC-Labeled, Sigma, 0.2 mg, 1.61 X 10-9 moles) in 0.2%
PBST solution at room temperature for 3 hrs, followed by extensive washing with PBST
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buffer for 30 mins and subjected to fluorescent imaging and the fluorescence intensity
was recorded as above. In the same condition, density controlled glycopolymer
microarray formation of glycopolymer 1b spaced with polyacrylamide-BA in different
ratios (as shown in Figure 8) were prepared and their lectin binding were tested,
respectively.
Similar protocol was followed for glycopolymer 1b microarray formation spaced
with other two boronic acid ligands conjugates (BSA-BA and Lyz-BA) in different ratios
(Figure 8) and their lectin (Arachis hypogae) binding assays, respectively.
Similar protocol was followed for spaced glycopolymer 1b microarray formation
spaced with these three boronic acid ligands in different ratios and their lectin Ricinus
communis (RCAI, FITC-labeled, EY Laboratories, Inc) binding assays, respectively
(Figure 10).

3.2.6 Control experiments for spaced glycopolymer microarray formation
Glycopolymer (1b, 3 mg) was mixed with unmodified lysozyme (3 mg) in 3 mL of 10.3
pH NaHCO3 buffer and was stirred at room temperature for 4 hrs. MicroCaster array tool
(Whatman, spot size 500 µm diameter) was inked with the glycopolymer/BSA solution (1
mg/mL) and then was printed onto amine functionalized glass slide in NaHCO3 buffer
(pH 10.3). The glass slide was then incubated in a humidifier chamber for 4 hrs and then
washed for with NaHCO3 buffer (pH 10.3) 30 mins (3 times) The glass slide was then
incubated with lectin-FITC (Arachis hypogae, FITC-Labeled, Sigma, 0.2 mg, 1.61 x 10-9
moles) in 0.2% PBST solution at room temperature for 3 hrs followed by extensive
washing with PBST buffer for 30 mins and subjected to fluorescent imaging and the
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fluorescence intensity was recorded as above. Same protocols were followed for
glycopolymer treated with unmodified BSA, respectively (Figure 9).
Same protocols were followed for printing glycopolymer with hydroxyl chain end
group and its complex with polyacrylamide-BA, respectively.

3.2.7 Surface Plasma Resonance (SPR) assay for immobilized glycopolymers spaced
with boronic acid ligands
3.2.7.1 Glycopolymer immobilization onto SPR chip: A CM5 chip (GE health science)
surface was activated with EDC/NHS 1:1 for 6 mins at 10 µL/min, treated with 70 µL of
0.1 M ethylenediamine in 8.5 pH 0.1 M borate buffer at 10 µL/min, followed by 70 µL of
1 M ethanolamine 8.5 pH 0.1 M borate buffer for 7 min at 10 µL/min. Once the amine
modified surface was generated, glycopolymer (1b) was immobilized by flowing
glycopolymer solution in 10.3 pH NaHCO3 buffer (0.5 mg/mL) for 7 min at 10 µL/min
followed by washing with 10.3 pH NaHCO3 buffer for 5 min (flow cell 2).
Immobilization of glycopolymer was confirmed by observing the increase in response
from the base line.
3.2.7.2 Boronic acid ligands spaced glycopolymer immobilization onto SPR chip: CM5
chip (GE health science) was modified as mentioned earlier to create amine
functionalization. Glycopolymer pre-modified with polyacrylamide-BA (0.5 mg/mL, 1:2
mol) in pH 10.3 NaHCO3 buffer was flowed for 7 min at 10 µL/min. Immobilization of
polyacrylamide-BA modified glycopolymer was confirmed by the increase in response
from the base line, followed by washing with 10.3 pH NaHCO3 buffer for 5 mins.
Polyacrylamide-BA was released from the immobilized glycopolymer by flowing with
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7.4 pH PBS buffer for 7 min. Same procedure was followed to immobilize lysozyme-BA
pre modified glycopolymer (1b).
3.2.7.3 Lectin binding onto immobilized glycopolymer: The binding of lectin to
immobilized glycopolymer was studied by flowing lectin (Arachis hypogae, Sigma).
Different concentrations of lectin ranging from 0.125 nmoles to 2 nmoles in 7.4 pH PBST
buffer were flowed through immobilized glycopolymer for 2 mins at 10 µL/min; and the
amplification of response with respect to increase in lectin concentration was illustrated.

3.3 Results and Discussion
3.3.1 Glycopolymer microarray formation and lectin binding assay
In our previous study, we have demonstrated that O-cyanate chain-end functionalized
glycopolymer could be immobilized onto amine-functionalized silica gel and glass slide
surfaces via isourea bond formation.24 To fully exploit the potential of the oriented
immobilized glycopolymer, herein, we examined molecular control of both the density of
glycan in the glycopolymer and the glycopolymer itself on the microarray surface. First,
we examined the glycan density effect for lectin binding in the glycopolymer by
synthesizing a series of glycopolymers with different ratios of pendant glycan and
molecular weights. Four glycopolymers were synthesized by our previously reported
method (Fig 2, Table 1).24
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Figure 2 1H NMR spectrum of glycopolymer 1a in D2O, 1b in D2O, 1c in D2O,1d in
D2O
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Table 1. O-cyanate chain-end functionalized glycopolymers of different densities

Glycopolymer

GM/AAa

GM/AAb

Mn(g/mol)c

1a

1/1

(1/18)12

20,700

1b

1/10

(1/30)12

38,800

1c

1/20

(1/54)4

17,200

1d

1/50

(1/51)4

16,300

a. Ratio of GM and AA added. b. Ratio of GM and AA determined by 1H NMR. c.
Molecular weight determined by 1H NMR analysis (D2O).

Then, glycopolymer microarrays (spot size about 500 µm diameter) were
fabricated by microcontact stamping (MicroCaster) of glycopolymers onto amine
functionalized glass slides (Xenopore Co.) in NaHCO3 buffer (pH 10.3). The glass slides
were incubated in a humidifier chamber for 4 hrs and then washed for 30 mins (3 times)
with respective buffers followed by washing with PBST to minimize the nonspecific
binding of proteins onto the surface. Then, the glass slides were incubated with lectinFITC (Arachis hypogae, FITC-labeled, Sigma) solution in PBST buffer for 3 hrs,
followed by extensive washing with PBST buffer for 30 mins, and are finally subject to
fluorescence imaging. As shown in Fig 3, glycopolymer (1b) with 1 to 30 ratio of
lactoseand acryl amide (LT/AA) showed the highest level of lectin binding (Fig 3B)
compared to the glycopolymers with 1 to 18 (1a) (Fig 3A), 1 to 54 (1c) (Fig 3C) and 1 to
51 (1d) (Fig 3D) ratio of lactose and acryl amide. These results indicated that the glycan
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density in the polymer has impact for the lectin binding. We chose glycopolymer 1b for
our continued density controlled glycopolymer microarray study below.

Figure 3. Fluorescence images of glycopolymer microarrays with different glycan
density after incubation with lectin (Arachis hypogae, FITC-labeled, Sigma). A:
glycopolymer 1a (LT/AA, 1:18), B: glycopolymer 1b (LT/AA, 1:30), C: glycopolymer
1c (LT/AA, 1:54), D: glycopolymer 1d (LT/AA, 1:51). LT: Lactose, AA: Acrylamide.
Bar size: 500 µm.

3.3.2 Syntheses and charecterization of boronic acid (BA) ligands
Three macro-boronic acid ligands (2), lysozyme-BA (2a, Mw: about 15 kDa), BSABA (2b, Mw: about 70 kDa) and polyacrylamide-BA (2c, Mw: about 10 kDa) conjugates
were designed and synthesized as spacing molecules to vary the immobilized
glycopolymer density since they have different molecular sizes and BA conjugation
density on it can be variable. Lysozyme-BA 2a and BSA-BA 2b conjugates were
synthesized by amidation of carboxylic acid groups in lysozyme and BSA with
aminophenyl boronic acid in the presence of EDC, respectively. Polyacrylamide-BA
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conjugate 2c was prepared as per our previously reported method.25 Lysozyme-BA and
BSA-BA conjugates were characterized by SDS-PAGE. As shown in Figure 4, the
comassie staining clearly showed large molecular weight shifts for the protein-BA
conjugates compared to unmodified BSA and lysozyme (Fig 4A). Interestingly, the gel
stained with Alizarin Red S. (ARS) in PBS buffer (pH 7.4) showed similar molecular
weight shifts for the conjugates but the color of the bands is brown comparing to yellow
band of the unmodified lysozyme and BSA. The ability of the boronic acid ligands to
specifically bind with carbohydrate was characterized by ARS-binding assay.26
Qualitative determination of boronic acid conjugation to both BSA and Lysozyme were
performed by Alizarin Red S assay. Briefly, Alizarin Red S (ARS) exhibits change in
fluorescence intensity and color by the addition of boronic acid. As shown in Figure 5,
ARS (a) showed a color change from pink to yellow when bound to boronic acid (b) and
also a shift in wavelength from 510 nm to 460 nm by UV absorption in PBS (pH 7.4)
buffer; and by adding free galactose, galactose -boronic acid complex was formed to
release ARS indicated by a color change from yellow to pink (c) with a shift in
wavelength to 510 nm from 460 nm. The same pattern of fluorescence intensity and color
change was observed by both BSA-BA and Lysozyme-BA conjugates as shown in Figure
5A: ARS plus Lyz (d) no color change, ARS plus Lyz-BA (e) color change from pink to
yellow and ARS-Lyz-BA plus galactose (f) color change back to pink, Figure 5B: ARS
plus BSA (g) no color change, ARS plus BSA-BA (h) color change from pink to yellow
and ARS-BSA-BA plus galactose (i) color change back to pink. (Fig 5).
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Figure 4. SDS-PAGE characterization of BSA-BA and lysozyme-BA conjugates: A.
stained with coomassie blue, B. stained with ARS in PBS buffer (pH 7.4) for 30 mins.

Figure 5. ARS assay of Lysozyme-BA (A) and BSA-BA (B) monitored by UV-Vis
Spectroscopy
Also quantitative determination of boronic acid in BSA-BA and Lysozyme-BA
conjugates was performed by monitoring ARS assay through fluorescence spectroscopy.
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Solutions of BSA-BA and Lysozyme-BA were added to 1 mM ARS solution in PBS (pH
7.4) buffer and fluorescence intensity was recorded at 378 nm. From the calibration curve
made with standard ARS and APBA below (Fig 6), the ratio of BA and protein obtained
was determined as shown in Table 2.

Figure 6. Calibration Curve of boronic acid by ARS assay monitored by Fluorescence
Spectroscopy

Table 2. Quantification of BSA-BA and Lyz-BA conjugates from ARS assay by
fluorescence spectroscopy
Protein-BA

Protein/APBAa (mole)

Protein/BAb(mole)

Lyz-BA

1/33

1/4

BSA-BA

1/87

1/54

a. Ratio of protein and APBA added. b. Ratio of BA and protein determined from
ARS assay.
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3.3.3 Density controlled glycopolymer microarray formation and lectin binding assays
Molecular imprinting technique has been recognized as a powerful tool for the
preparation of synthetic polymers with molecular sized cavities that are capable of
molecular recognition.27-28 This technique has been used for chromatographic
separations,29 solid phase extraction,30 binding assay31 and sensors,32-33 and drug
delivery34 applications. Boronic acid-carbohydrate complex formation is a pH-dependent
reversible process and has been used for the preparation of molecularly imprinted
polymers targeting sugars.35-38 In the present study, we envisioned that the reversible
interaction between boronic acid and carbohydrate can be used to modulate the density of
immobilized glycopolymer on the microarray surface by using boronic acid ligands in
different sizes as “temporary spacing molecules”. Briefly, the glycopolymer was precomplexed with boronic acid liands. These assemblies were then printed onto the
microarray surface, in which the boronic acid ligands temporarily occupy space between
the immobilized glycopolymers. Once the immobilization was complete, the spacer
boronic acid ligands are removed leaving empty space behind and thus afforded density
controlled glycopolymer microarray. The key factor for this innovative fabrication of
density controlled glycopolymer microarray is the compatible conditions, first the basic
condition for both boronic acid and carbohydrate complex formation and O-cyanatebased isourea bond formation immobilization; second, neutral condition for removal of
spacer boronic acid ligands from the microarray surface (Fig 1).
The O-cyanate chain end functionalized lactose-containing glycopolymer 1b,
which showed the highest lectin binding above, was used as a model glyco-macroligand
for oriented and density controlled glycopolymer microarray formation.
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The general process for oriented and density controlled glycopolymer microarray
formation includes three steps as shown in Fig 1. First, prior immobilization, the
complexes formation between glycopolymer (1b) and spacing broronic acid ligands (2)
were conducted by mixing 1b and 2 in NaHCO3 buffer (pH, 10.3) for 4 hrs at room
temperature. Next, MicroCaster array tool (Whatman, spot size 500 µm diameter) was
inked with the solution of glycopolymer-boronic acid ligand complex in NaHCO3 buffer
(pH, 10.3), then was pressed onto an amine functionalized glass slide (Xenopore, Co) for
10 mins at room temperature. The glass slide was then incubated in a humidifier chamber
for 4 hrs at room temperature. Finally, the spacing boronic acid ligands were detached
from the immobilized glycopolymer by incubating the glass slides in PBS buffer (pH 7.4)
solution in the presence of high concentration glucose (1 mM) as well, and followed by
washing with PBS buffer (pH 7.4) for 30 mins (3 times) so as to afford the expected
oriented and density controlled glycopolymer microarrays. ARS assay was also used to
confirm the boronic acid ligands detached from the immobilized glycopolymer, in which
PBS buffer solution containing ARS turned to brown color from red color upon falling in
of detached boronic acid ligands from the immobilized glycopolymers on the microarray
surface (Fig 7).

60

Figure 7. UV spectra of ARS and ARS upon boronic acid ligand detached from the glass
slide in PBS buffer (pH7.4). BP: polyacrylamide-boronic acid
For protein binding, the resultant glycoarray glass slides were washed with PBS
containing 0.2% tween 20 (PBST) first to minimize nonspecific protein binding, then
incubated with β-galactose specific lectin (Arachis hypogae (PNA) FITC- Labeled,
Sigma) solution in PBST buffer (pH 7.4, 0.2 mg/mL) for 3 hrs at room temperature
followed by extensive washing with PBST buffer for 1 hr. The slides then were subjected
to fluorescence imaging. As results, all spaced glycopolymer microarrays showed
enhanced lectin binding compared to non-spaced one (Fig 8). Among them, the
polyacrylamide-BA spaced glycopolymer showed the highest enhanced lectin binding
(Fig 8A), while BSA-BA spaced glycopolymer and lysozyme-BA spaced glycopolymer
showed moderately enhanced lectin binding (Fig 8B and 8C). Significantly,
glycopolymer microarrays spaced with boronic acid ligands in different sizes showed
different levels of lectin bindings (Fig 8A, 8B, 8C). Specifically, the polyacrylamide-BA
spaced glycopolymer showed its highest level of lectin binding with the
glycopolymer/polyacrylamide-BA ratio of 1 to 6 (mol) (Fig 8A3), while the lysozyme61

BA spaced glycopolymer showed its highest level of lectin binding with the
glycopolymer/lysozyme-BA ratio of 1 to 2 (mol) (Fig 8B2), and BSA-BA spaced
glycopolymer showed its highest lectin binding with the glycopolymer/BSA-BA ratio of
1 to 0.6 (mol) (Fig 8C3), both of which are lower than that of polyacrylamide-BA spaced
glycopolymer microarray (Fig 8A3). These results indicated that glycopolymer
microarrays with different densities can be made with different boronic ligands in
different ratios and hence revealed relevant protein bindings.

Figure 8. Fluorescence images of density controlled glycopolymer microarrays spaced
with boronic acid ligands in different molar ratios after incubation with lectin (Arachis
hypogae (PNA), FITC-Labeled, Sigma) and their fluorescence intensities: A1-A4.
glycopolymer spaced with polyacrylamide-BA in different ratios, B1-B4. glycopolymer
spaced with lysozyme-BA in different ratios, C1-C4. glycopolymer spaced with BSA-BA
in different ratios. Bar size: 500 µm. GP: glycopolymer, PA-BA: polyacrylamide-BA,
LYZ-BA: lysozyme-BA.
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It should be noted that both the glycopolymer and the boronic acid ligands have
multi-binding sites and thus could afford a mixture of conjugates or form aggregates due
to the multivalent interactions. In current study, low concentrations (mg/mL) of both
polymers were used and no aggregates were observed.
The spaced glycopolymer microarrays formations were reproduced with the
highest lectin binding (Fig 9A-C). In addition, control experiments for glycopolymer
microarray formation with unmodified lysozyme and BSA showed no enhanced lectin
binding compared to glycopolymer alone microarray (Fig 9C1, 9C2, 9D). On the other
hand, no glycopolymer microarray formed when the chain end O-cyanate group was
converted to hydroxyl group in the glycopolymer16 (Fig 9C3 and 9C4). Overall, these
results indicated the successful oriented and density controlled glycopolymer microarray
formation and that the immobilized glycopolymer density had a substantial effect on its
lectin recognition.
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Figure 9. Fluorescence images of density controlled glycopolymer microarrays after
incubation with lectin (Arachis hypogae, FITC-Labeled, Sigma) and their fluorescence
intensities: A. glycopolymer spaced with polyacrylamide-BA (1:6 mol), B. glycopolymer
spaced with lysozyme-BA (1:2 mol), C. glycopolymer spaced with BSA-BA (1:0.6 mol),
C1. glycopolymer treated with lysozyme (1:2 mol), C2. Glycopolymer treated with BSA
(1:0.6 mol), C3. glycopolymer-OH, C4. glycopolymer-OH treated with polyacrylamideBA (1:6 mol), and D. glycopolymer alone. Bar size: 500 µm.
Next, the oriented and density controlled glycopolymer microarrays above were
also tested for lectin Ricinus communis (RCAI, FITC-labeled, EY Laboratories, Inc)
binding, which recognizes β-galactose too. Interestingly, different from lectin Arachis
hypogae bindings above, RCAI showed stronger bindings to polyacrylamide-BA spaced
glycopolymer with the glycopolymer/polyacrylamide-BA ratio of 1 to 4 (mol) (Fig 10A2)
and lysozyme-BA spaced glycopolymer with the glycopolymer/lysozyme-BA ratio of 1
to 2 (mol) (Fig 10B2), and BSA-BA spaced glycopolymer showed stronger lectin binding
with the glycopolymer/BSA-BA ratio of both 1 to 0.4 and 1 to 0.6 (mol) (Fig 10C2 and
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10C3). Both lectin Ricinus communis and lectin Arachis hypogae have four binding
sites and about 120 kDa molecular weight. However, they prefer different spacer distance
and glycan density. This different binding preference might be due to different location
geometry of their binding sites in the protein or the protein conformation. Overall, these
observations indicated that arrayed glycopolymers with controlled ligand density
facilitate optimized protein binding, which will be important for studying glycan-protein
interaction, such as assessing multivalent glycans in parallel in a microchip format.

Figure 10. Fluorescence images of density controlled glycopolymer microarrays spaced
with boronic acid ligands in different molar ratios after incubation of with lectin Ricinus
communis (RCAI), FITC-labeled, EY Laboratories, Inc) and their fluorescence
intensities: A1-A4. glycopolymer spaced with polyacrylamide-BA in different ratios, B1B4. glycopolymer spaced with lysozyme-BA in different ratios, C1-C4. glycopolymer
spaced with BSA-BA in different ratios. Bar size: 500 µm. GP: glycopolymer, PA-BA:
polyacrylamide-BA, LYZ-BA: lysozyme-BA.
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3.3.4 Surface Plasma Resonance (SPR) assay for boronic acid ligands imprinted
glycopolymer
The interaction of lectin with oriented multivalent glycans in different densities was
also investigated with surface plasmon resonance (SPR). The major advantages of this
assay are that it is a label free assay and monitors binding in real time. Three different
density controlled immobilized glycopolymers were made onto CM5 chip (GE health
science), in which the active ester NHS was first converted to amine surface by reacting
with ethylene diamine and followed by O-cyanate-based glycopolymer immobilization
similarly as described for glycopolymer microarray formation above. Briefly, CM5 chip
was treated with EDC/NHS first, then with ethylene diamine in borate buffer (pH 8.5),
followed by 1 M ethanolamine in borate buffer (pH 8.5) to quench all NHS on the chip
surface.

Once

the

amine

modified

surface

is

formed,

glycopolymer,

glycopolymer/lysozyme-BA, glycopolymer/polyacrylamide-BA complexes (5 mg/mL,
NaHCO3 buffer (pH 10.3) were flowed over the chip for 7 mins at 10 µL/min and
followed by washing with NaHCO3 buffer (pH 10.3) for 5 mins, respectively. Finally,
flowing PBS (pH 7.4) buffer for 7 mins 10 µL/min to remove the boronic acid ligands
afforded the oriented and density controlled glycopolymer on the SPR chip surface.
Binding of lectin to the immobilized glycopolymers were assessed by flowing lectin
(Arachis hypogae, Sigma) over the chip at various concentrations (0.125 nM, 0.25 nM,
0.5 nM, 1 nM, 2 nM.) and recording the SPR sensorgrams (10 μL min−1, 25 °C). As
shown in Figure 11, glycopolymer spaced with different boronic acid ligands showed
different level of lectin bindings. Among them, the polyacrylamide-BA spaced
glycopolymer showed the highest lectin binding (Fig 11A, track 3), while glycopolymer
66

alone showed the least lectin binding (Fig 11A, track 1). These results are consistent
with glycoarray results above (Figure 11B). These results further demonstrated that the
density of the multivalent glycan displaying plays a critical role for enhancing their
interactions with proteins.

Figure 11. Specific binding of lectin (Arachis hypogae, FITC-labeled, Sigma) onto
oriented and density controlled glycopolymers on SPR surface (A) and microarray (B): 1.
Glycopolymer, 2. Glycopolymer spaced with lysozyme-BA (1:2 mol), 3. Glycopolymer
spaced with polyacrylamide-BA (1:6 mol). Bar size: 500 µm.

3.4 Conclusion
We have demonstrated an oriented and density controlled glycopolymer microarray
formation based on end-point immobilization of glycopolymer that was spaced with
boronic acid ligands of different sizes. Our studies confirmed that end-point immobilized
glycopolymers with density control of both glycan in the polymer and glycopolymer on
the microarray surface can effectively engage glycan-binding proteins and function as
novel glycan microarray format. Lectins that bind the same glycan are affected by the
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glycopolymer density in unique ways. The reported well-defined glycopolymer
microarray in both orientation and glycan density can be utilized for various biological
analyses such as profiling the glycan–protein interactions and clinical antibody detection
and profiling, vaccine development, biomarker discovery, and drug screening
applications.
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CHAPTER IV

IMMOBILIZED SIALYLOLIGO-MACROLIGAND AND ITS
PROTEIN BINDING SPECIFICITY

4.1 Introduction
Sialic acids are a family of 9-carbon containing acidic monosaccharides, often
terminate oligosaccharide structures of cell surface glycoconjugates such as glycoproteins
and glycolipids and are involved in many biological recognition systems. For example,
sialic acid expressed on respiratory epithelial cell surface is involved in influenza virus
infection in both virus hemagglutinin-based attaching1 and neuraminidase-based
detaching2 processes. The mechanisms by which influenza virus recognizes sialic acid
have therefore been very important targets to design anti-influenza agents.3 To date, two
effective neuraminidase inhibition-based anti-influenza drugs, zanamivir and oseltamivir,
have substantially improved antiviral therapy for influenza infection.4-5 On the other
hand, site-specific blocking of the viral hemagglutinin binding to host cell receptors with

72

sialic acid derivatives has been intensively investigated for antiinfluenza drug
development.6
Influenza virus contains about 350-400 HA trimers7 and 50 NA tetramers8 on its
surface, which facilitate strong binding affinity through multivalent interactions with the
sialic acid receptors on the host cell surface. Previous efforts using sialic acid-bearing
macromolecules provided a proof of the concept of multivalent hemagglutinin
inhibition.6 However, the monosaccharide sialic acid cannot account for the molecular
determinant of virus receptor-binding specificity in the context of the whole
sialyloligosaccharide receptor. Recently, it has been known that the host cell binding
specificity and affinity of influenza viruses depend on not only sialic acid but also the
penultimate sugar and the linkage of sialic acid to the penultimate sugar in the receptor.
For example, Siaα2,6Gal is indispensable receptor for the human-to-human spread of the
influenza virus, while Siaα2,3Gal is the receptor for avian influenza virus infection.9-10
Therefore, sialyoligosaccharide is likely the choice as an active ligand for specific and
stronger influenza HA binding and thereby a multivalent sialyloligosaccharide would be
rational influenza HA inhibitors. During the past decade, several sialyloligosaccharidecontaining macromolecules have been demonstrated to inhibit influenza virus attachment
to target cells and suppress the virus-mediated hemagglutination and neutralize virus
infectivity in cell culture.11
Glycopolymers, namely polymers with carbohydrate pendent groups, have been
extensively explored for different biological and biomedical applications.12-13 It is
generally accepted that glycopolymers can mimic the functions of naturally occurring
glycoconjugates14-15 and have been employed as cell-surface binding receptors.16 The
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strength and selectivity of binding interactions between multivalently displayed
carbohydrates and targets are likely to depend on the density and relative spatial
arrangement of the carbohydrate residues on the glycopolymers. Recently, the potential
utility of glycopolymers in bio- and immunochemical assays as biocapture reagents and
for microarray applications have been demonstrated by adding functional anchor group
either as a pendant to the polymer backbone or at the chain end.17 Particularly, the chainend groups of glycopolymers are the focus for bio-functionalization, as they allow for a
direct one-to-one attachment18-19 and also facilitate site specific20

and oriented

immobilization on solid surfaces.21 This molecular recognition pattern is especially
exploited on solid surfaces for the development of biosensors, chip-based bioassays, and
cell-adhesion studies22 as they mimic the three dimensional (3D) display of glycans on
the cell surface. Recently, Bertozzi’s group23 and our group24 reported oriented
glycopolymer microarrays based on end-point immobilization of glycopolymers to mimic
3D natural cell surface glycan displaying. In these approaches, the densities and
orientations of the glycan ligands are determined by the polymer structure rather than by
features of the underlying microarray surface. These parameters should therefore be more
controllable than in the case with conventional 2D glycan microarrays. In our previous
study, O-cyanate chain-end functionalized glycopolymer provides an anchor for sitespecific and covalent immobilization of the glycopolymer onto an amine surface via
isourea bond formation and thereby facilitates an oriented glyco-macroligand
formation.24 Herein, we report a chemoenzymetic synthesis of O-cyanate chain-end
functionalized sialyllactose-containing glycopolymers and their oriented sialyloligomarcroligand formation for glycoarray and glyco-biosensor applications (Fig 1).
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Particularly, O-cyanate chain-end functionalized sialyllactose-containing glycopolymer
was immobilized onto amine-modified glass slide and SPR chip via isourea bond
formation, respectively. This oriented sialyloligo-macroligand microarray and SPR-based
glyco-biosensor platform are expected to facilitate both affinity and specificity of protein
binding and thus will provide a versatile tool for profiling glycan recognition for both
basic biological research and practical applications.

Figure 1. Chemical structure of O-cyanate chain-end functionalized sialyllactosecontaining glycopolymers and their oriented immobilization via isourea bond formation
for microarray and SPR applications.

4.2 Experimental
4.2.1 Materials and methods
All solvents and reagents were purchased from commercial sources and were used as
received, unless otherwise noted. CMP-Neu5Ac, α2,3-sialyltransferase and α2,675

sialyltransferase were purchased from Sigma. FITC-labeled MAA (Macckia amurensi)
and SNA (Sambucus nigra) were purchased from Bioworld (Dublin, OH). Avain HA
(A/Anhui/1/2005(H5N1)) and human HA (A/Brisbane/10/2007(H3N2)) were purchased
from Sino Biological (China). O-Cyanate chain-end functionalized lactose-containing
glycopolymer was synthesized as previously reported.24

4.2.2 Enzymatic synthesis of sialyllactose glycopolymers (SGPs)
O-Cyanate chain-end functionalized lactose-containing glycopolymer (40 mg, 1 µmole,
10 µmoles of lactose) was dissolved in 2 mL of buffer [Triton X-100 (0.5%) + HEPES
(0.10 M) + MgCl2 (5 mM) + MnCl2 (2 mM) + ZnCl2 (5 x 10-5 M), pH 7.4]. To the
dissolved polymer, CMP-Neu5Ac (6.5 mg, 100 µmoles), calf alkaline phosphate (10 U),
bovine serum albumin (0.8 mg), and α2,3-sialyltransferase (0.5 U) were added and the
mixture was stirred gently at room temperature for two days (48 hrs). The resultant α2,3sialyllacotose glycopolymer (α2,3SGP) was purified by gel-filtration with Sephadex G25 column (eluted with water) and the fractions containing SGP were confirmed with
phenol sulfuric acid assay. The same protocol was employed to synthesize α2,6sialyllacotose glycopolymer (α2,6SGP) by using α2,6-sialyltransferase, the O-cyanate
chain-end functionalized lactose-containing glycopolymer and CMP-Neu5Ac. The
resultant SGPs were characterized by 1H NMR spectrometry.
α2,6SGP ( 4): Molecular Weight: 17,600 (determined by 1H NMR) ; 1H NMR (D2O, 400
MHz) δ(ppm): 7.21, 7.06 (H of phenyl), 4.36, 4.33 (H1 of Gal and H1 of Glc), 3.85-3.36
(H of Gal and Glc), 3.28-3.20 (H of -OCH2CH2O-, linker), 2.56 (H3eq of Neu5Ac), 2.20-
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1.94 (-CH- of polymer backbone), 1.89 (CH3 of Neu5Ac), 1.70-1.30 (-CH2- of polymer
backbone).
α2,6SGP (5): Molecular Weight: 17,600 (determined by 1H NMR); 1H NMR
(D2O, 400 MHz) δ(ppm): 7.20, 7.04 (H of phenyl), 4.36, 4.33 (H1 of Gal and H1 of Glc),
3.95-3.40 (H of Gal and Glc), 3.28-3.18 (H of -OCH2CH2O-, linker), 2.60 (H3eq of
Neu5Ac), 2.20-1.94 (-CH- of polymer backbone), 1.89 (CH3 of Neu5Ac), 1.70-1.30 (CH2- of polymer backbone).

4.2.3 Sialyllactose glycopolymer microarray fabrication
MicroCaster microarray tool (Whatman, spot size 500 µm diameter) was inked with a
solution of α2,3SGP in NaHCO3 buffer (pH 10.3, 2.1 x 10-2 mM), then was pressed onto
amine functionalized glass slides (Xenopore, Co) at room temperature for 10 min. The
glass slides were then incubated in a humidifier chamber at 37 oC for 4 h and then
washed with NaHCO3 buffer (pH 10.3) (30 min, 3 times) and followed by washing with
0.2% PBST buffer (pH7.4). Then the array glass slides were incubated with lectin MAAFITC (Macckia amurensis, 1.4 x 10-3 mM, Bioworld) in 0.2% PBST buffer (pH 7.4) at
room temperature for 3 h and followed by extensive washing with 0.2% PBST buffer (pH
7.4) for 30 min and finally subjected to fluorescent imaging. As control experiments, the
α2,3SGP printed glass slides were incubated with lectin SNA-FITC (Sambucus nigra,1.3
x 10-3 mM, Bioworld), PNA-FITC (Arachis hypogaea, 1.6 x 10-3 mM, Sigma), MAAFITC (0.2 mg, 1.4 x 10-3 mM, Bioworld) that was pre-incubated with α2,3-sialyllactose
(1.5 x 10-2 mM, V-Labs), α2,6-sialyllactose (1.5 x 10-2 mM, V-Labs) and free sialic acid
(3.2 x 10-2 mM, Rose Scientific ltd ) in 0.2% PBST buffer (pH 7.4) at room temperature
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for 2 h, respectively, and followed by extensive washing with 0.2% PBST buffer (pH 7.4)
for 30 min and finally subjected to fluorescent imaging, respectively.
The same protocol was used for α2,6SGP microarray fabrication and followed by
incubation with lectin SNA-FITC (1.3 x 10-3 mM). As control experiments, the α2,6SGP
printed glass slides were incubated with lectin MAA-FITC (1.3 x 10-3 mM), lectin SNAFITC (1.4 x 10-3 mM) that was pre-incubated with α2,6-sialyllactose (1.5 x 10-2 mM),
α2,3-sialyllactose (1.5 x 10-2 mM) and free sialic acid (3.2 x 10-2 mM), PNA-FITC
(Arachis hypogaea, 1.6 x 10-3 mM, Sigma) in 0.2% PBST buffer (pH 7.4) at room
temperature for 2 h, respectively, and followed by extensive washing with 0.2% PBST
buffer (pH 7.4) for 30 min and finally subjected to fluorescent imaging, respectively.

4.2.4 SPR analysis of specific MAA and SNA binding to immobilized α2,3SPG and
α2,6SGP
The specific binding of lectin to immobilized SGP was analyzed with SPR with a BI
2000 biosensor system (BI Biosensing Instruments). To prepare the sensing surface, the
commercial SPR gold chip (BI Biosensing Instuments) was rinsed with piranha solution
of sulfuric acid and hydrogen peroxide (1:1, v/v), followed by water and ethanol (3 times)
and dried under nitrogen. The dried gold chip was incubated with 1 mg/mL of cystamine
solution in ethanol at 4 ˚C overnight and followed by washing with ethanol and water to
remove weakly adsorbed cystamine to generate amine functionalized gold chip surface.
Next, α2,3SGP was covalently immobilized onto the amine functionalized gold chip
surface by flowing the polymer solution (2 mg/mL, NaHCO3 buffer (pH 10.3)) at a flow
rate of 10 µL/min for 600 sec and repeated at least 3 times until the surface is saturated
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with the polymer, NaHCO3 buffer (pH 10.3) was used as a running buffer. Then a serial
of solution of lection MAA in concentration ranging from 0.5 µM to 10 µM in PBS
running buffer (pH 7.4) were injected over the immobilized α2,3SGP at a flow rate of 20
µL/min for 2 min (120 sec, association phase). For regeneration of the surface, 0.1 M
HCl (pH 1.5) was injected at a flow rate of 20 µL/min for about 30 sec and sometimes
repeated twice to remove bound lectin completely. The association and dissociation
constants of the lectin binding to immobilized SGP were determined by standard BI 2000
(scrubber) evaluation software. For the experiments with α2,6SGP, the same surface
modification procedure was followed as above. For lectin SNA binding, the same
procedure was used as above except different concentrations ranging from 1 µM to 10
µM used.

4.2.5 Competitive binding assay of lectin to immobilized SGP
Both α2,3SGP and α2,6SGP were immobilized on the gold sensor chip by following the
same procedure as above. Solutions of MAA and SNA were prepared in PBS buffer (pH
7.4, 10 µM) and were pre-incubated with a series of α2,3-sialyllactose and α2,6sialyllactose in concentrations ranging from 0.075 nM to 7.5 nM, respectively. As
control, MAA and SNA (10 µM) were pre-incubated with high concentration (7.5 nM) of
2,6-sialyllactose and 2,3-sialyllactose, respectively. These pre-incubated MAA and SNA
were injected over the immobilized α 2,3SGP and α2,6SGP at a flow rate of 20 µL/min
for 3 min (180 sec, association phase), respectively. For regeneration of the surface, 0.1
M HCl (pH1.5) was injected at a flow rate of 20 µL/min for 30 sec. The response of the
binding was calculated by standard BI 2000 (scrubber) evaluation software.
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4.2.6 Hemagglutintin (HA) binding to immobilized SGP
Both α2,3SGP and α2,6SGP were immobilized on the gold sensor chip following the
same procedure as above. Solutions of H5N1 HA (A/Anhui/1/2005(H5N1)) and H3N2
HA (A/Brisbane/10/2007(H3N2)) (Sino Biological, China) were prepared in PBS buffer
(pH 7.4 pH, 420 nM), then were injected over the two immobilized α2,3SGP and
α2,6SGP at a flow rate of 20 µL/min for 180 sec, respectively. As control, both H5N1
HA and H3N2 HA were pre-incubated with α2,3-sialyllactose (PBS buffer (pH 7.4), 5 x
10-6 mM) and α2,6-sialyllactose (PBS buffer (pH 7.4), 5 x 10-6 mM) for 30 min, and then
injected over immobilized α2,3SGP and α2,6SGP, respectively. 100 mM NaOH was
injected for regeneration of surface between each HA injections. The association and
dissociation constants of the protein to immobilized SGP were determined by standard BI
2000 (scrubber) evaluation software.

4.3 Results and Discussion
4.3.1 Synthesis and characterization of O-cyanate chain-end functionalized
sialyllactose glycopolymers
Recently, a variety of methods have been developed for the synthesis of chain-end
functionalized glycopolymers for potential biomedical applications such as protein
modification and microarray fabrication applications.17 We have demonstrated that
cyanoxyl mediated free-radical polymerization is a straightforward approach to
synthesize O-cyanate chain-end functionalized glycopolymer that could be immobilized
onto amine functionalized silica gel beads via isourea bond formation and amine
functionalized

glass

slide

for

oriented
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glycopolymer

microarray

fabrication

applications.24 Particularly, the polymerization could be conducted in aqueous solution,
tolerant of a broad range of functional groups including -OH, -NH2, -COOH, and SO3moieties, and yield glycopolymers with low polydispersity (PDI < 1.5). In this study, an
O-cyanate chain-end functionalized lactose-containing glycopolymer (3) was synthesized
as described in our previous report,24 and then enzymatic sialylation of the terminal
galactose (Gal) pending on the polymer was investigated for synthesizing O-cyanate
chain-end

functionalized

silallylactose-containing

glycopolymer.

The

enzymatic

approach for transferring sialic acid from CMP-Neu5Ac to the non-reducing end of the
carbohydrate acceptor was extensively reported.25 The glycosidic linkage between the
sialic acid and the acceptor carbohydrate is extremely controlled by the type of
sialyltranferase selected. The transfer of sialic acid residue from CMP-Neu5Ac to 3- and
6-positions of terminal Gal of lactose glycopolymer (3), by enzymes α2,3sialyltransferase

and

α2,6-sialyltransferase

afforded

silallylactose-containing

glycopolymer α2,6SGP (4) and α2,3SGP (5), respectively (Scheme 1). The resultant
SGPs were characterized by 1H NMR spectra. The successful sialyation of lactose
glycopolymer was confirmed by the signals of protons from Neu5Ac (1.95 ppm, CH3Neu5NAc and 2.60 ppm, H3eq-Neu5Ac), the degree of sialyation and the polymer length
as well were calculated also using the 1HMR spectra by comparing the integration value
of proton signals from aromatic protons (7.21 ppm and 7.06 ppm), anomeric protons
(4.36 ppm and 4.33 ppm) of Gal and Glc, and C3-equatorial proton (2.60 pm) of Neu5Ac
as shown in Figure 2. By comparing the integrated signal from the anomeric protons of
Gal and Glc (4.36 ppm and 4.43 ppm,) with that of the C3-equatorial proton of Neu5Ac
(2.60 ppm, H3eq-Neu5Ac), the percentages of both sialyalations were more than 90%.
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Scheme 1. Chemoenzymatic synthesis of O-cyanate chain-end functionalized
sialyllactose-containing

glycopolymers

via

polymerization followed by enzymatic sialylation.

82

cyanoxyl

mediated

free

radical

Figure 2. 1H NMR spectra of glycopolymers in D2O: A. lactose glycopolymer (3), B.
α2,6-sialyllactose glycopolymer (4), C. α2,3-sialyllactose glycopolymer (5).
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4.3.2 SGP Microarray fabrication and its specific lectin binding
SGP-based microarrays were fabricated by printing O-cyanate chain-end SGP onto
amine functionalized glass slide. Briefly, α2,3SGP and α2,6SGP were printed (sport size
500 µm diameter) on amine functionalized glass slides (Xenopore Co) with MicroCaster
in NaHCO3 buffer (pH 10.3). The glass slides were incubated in humidifying chamber at
37oC for 4 h and then washed with NaHCO3 buffer and followed by washing with PBS
buffer (pH 7.4) containing 0.2% tween 20 (PBST) in order to minimize nonspecific
binding of proteins onto the glass surface later. Next, the specific lectin binding ability of
the SGP-based microarray was performed. The resultant α2,3SGP and α2,6SGP printed
glass slides were incubated with respective FITC-labeled lectins, Macckia amurenisis
(MAA) and Sambucus nigra (SNA) (Bioworld) in PBST buffer (pH 7.4) followed by
extensive washing with PBST buffer (pH 7.4) and finally the glass slides were subjected
to fluorescent imaging, respectively. Lectin MAA that has affinity for α2,3-linked sialic
acid showed binding to α2,3SGP (Fig 3Ia), while lectin SNA which has affinity for α2,6linked sialic acid showed no binding to α2,3SGP (Fig 3Ib). To confirm the specific
binding, competitive inhibition assays were performed as by incubating the α2,3SGP
arrayed glass slides with lectin MAA that was pre-incubated with α2,6-siallylactose,
α2,3-siallylactose and free sialic acid, respectively. As a result, MAA pre-incubated with
α2,3-sialyllactose showed no binding to α2,3SGP (Fig 3Id), while MAA pre-incubated
with α2,6-siallylactose and free sialic acid still showed lectin binding to α2,3SGP (Fig
3Ic and 3Id). On the other hand, lectin MAA showed no binding to α2,6SGP (Fig 3IIa),
while lectin SNA showed binding to α2,6SGP (Fig 3IIb). Same pattern of inhibition
assays were performed by incubating α2,6SGP arrayed glass slides with SNA that was
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pre-incubated with α2,6-sialyllactose, α2,3-sialyllactose and free sialic acid, respectively.
As a result, SNA pre-incubated with α2,6-sialyllactose showed no binding to α2,6SGP
(Fig 3IIc), while SNA PI with α2,3-siallylactose and free sialic acid still showed lectin
binding to α2,6SGP (Fig 3IId and 3IIe). In addition, in order to determine the quantitative
sialyation of lactose glycopolymer (3), both α2,3SGP and α2,6SGP printed glass slides
were incubated with lectin PNA that has specificity to α-galactose on the starting
glycopolymer (3). As a result, no apparent PNA binding was observed for both α2,3SGP
and α2,6SGP printed glass slides (Fig 3If and 3IIf), which indicated that there were no
lactose left on the glycopolymer after enzymatic sialylation. Overall, these observations
indicate that arrayed SGPs are capable of distinguishing different glycan-binding protein
based on their sialic acid linkage to the galactose in the SGPs.
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Figure 3. Fluorescence images of α2,3SGP and α2,6SGP microarrays: I. α2,3SGP array
incubated with FITC-labeled lectin, a. MAA, b. SNA, c. MAA pre-incubated with α2,6sialyllactose (α2,6SL), d. MAA pre-incubated with α2,3-sialyllactose (α2,3SL), e. MAA
pre-incubated with free sialic acid (SA), and f. PNA; II. α2,6SGP array incubated with
FITC-labeled lectin, a. MAA, b. SNA, c. SNA pre-incubated with α2,6SL, d. SNA preincubated with α2,3SL, e. SNA pre-incubated free SA, and f. PNA. Bar size: 500 µm.
[MAA: Macckia amurensis, SNA: Sambucus nigra, PNA: Arachis hypogaea]

4.3.3 Surface Plasmon Resonance (SPR) analysis of lectin binding to immobilized SGP
The interaction of lectin with oriented immobilized SGPs was also investigated with
SPR (BI 2000, Biosensing Instrument). The major advantages of SPR assay are that it is a
label free assay and monitors the binding in real time. Initially, the gold sensor chip was
functionalized with amine by treating the sensor chip with cysteamine in ethanol
overnight, the monolayer formation on the sensor chip was confirmed by increase in the
resonance units upon modification of the chip (data not shown). Next, α2,3SP was
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covalently immobilized onto the amine modified sensor chip at a flow rate of 5 μL/min in
NaHCO3 buffer (pH 10.3) in flow cell one for 10 min while the flow cell two was used a
control to subtract the non-specific binding to the surface. Glycopolymer immobilization
was repeated until there is no further immobilization observed at fourth time (Fig 4A1-4).
Then, a various concentrations of MAA in PBS buffer (pH 7.4) were injected over the
α2,3SGP modified sensor chip at a flow rate of 20 μL/min for 2 min. A typical
sensogram was obtained as increased binding of lectin to the SGP was observed with
increasing lectin concentration (Fig 5A and 5A1). In contrast, only a negligible binding
was observed when lectin SNA was injected over α2,3SGP (Fig 6A2), verifying the
specific binding of SGP to its specific lectin. Similar experiments were performed with
α2,6SGP immobilization onto the chip surface (Fig 4B1-4) and its lectin binding
monitored by SPR. As a result, specific SNA binding to immobilized α2,6SGP was
observed as shown in Figure 5B, 5B1 and Figure 6A1, while a negligible binding was
observed when lectin MAA was injected over α2,6SGP (Fig 6B2). The dissociation
constant (kd) values for MAA and SNA for their respective SGP were determined.
Interestingly, MAA and SNA have similar association constant (ka) values for α2,3SGP
and α2,6SGP, respectively (Table 1). However, the kd were relatively different, the kd of
SNA from α2,6 SGP was observed to be almost 14 fold higher than that of MAA from
α2,3SGP. This indicated that the binding of MAA to α2,3SGP is stronger when compared
to that of SNA to α2,6SGP.

87

Figure 4. SPR sensorgrams of SGP immobilization: A. α2,3SGP immobilization, B.
α2,6SGP immobilization. 1. First Injection, 2. Second injection, 3. Third injection, 4.
Fourth injection.
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Figure 5. SPR sensorgrams of lectin binding onto SGP: A. different concentrations of
MAA binding to α2,3SGP; A1. Steady state binding response of MAA to α2,3SGP; B.
different concentrations of SNA binding to α2,6SGP; B1. Steady state binding response
of SNA to α2,6SGP.
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Figure 6. SPR sensorgrams of lectin SNA (A) and MAA (B) binding to SGP: A1. SNA
(5 µM) binding to immobilized α2,6SGP; A2. SNA binding to immobilized α2,3SGP;
B1. MAA (5µM) binding to immobilized α2,3SGP; B2. MAA binding to immobilized
α2,6SGP.
Table 1. Binding kinetics of lectins to immobilized SGPs in SPR assays
Glycopolymer Lectin

ka (M-1s-1)

kd (s-1)

KD (M)

α2,3SGP

MAA

4.39 x 103

9.08 x 10-4

2.06 x 10-7

α2,6SGP

SNA

4.69 x 103

1.25 x 10-2

2.60 x 10-6

4.3.4 Competitive binding assay of lectin to immobilized SGP
Next, competitive binding assays were conducted to confirm the specific lectin
binding to immobilized SGP by pre-incubating the lectin with free ligands. Briefly, the
SGP were immobilized onto SPR chip as described above. The lectin was pre-incubated
with different concentrations of sialyllactose (α2,3SL for MAA and α2,6SL for SNA) in
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PBS buffer (pH 7.4) for 30 min before injecting over the immobilized SGP. It was
observed that by increasing the concentration of sialyllactose (from 0.75 nM to 7.5 nM)
the binding of lectin to immobilized SGP is reduced significantly as shown in Figure
7Aa-b for α2,3SGP and Figure 7Ba-b for α2,6SGP, whereas when the lectins were preincubated with non specific sialyllactose i.e. MAA with α2,6SL (Fig 7A-e) and SNA with
α2,3SL (Fig 7B-e), there was no inhibition observed. Even in higher concentration of 7.5
nM, there is no inhibition in lectin binding to their corresponding SGP when compared to
the lectins pre-incubated with specific sialyllactose (Fig 7A1and B1). This was due to the
fact that sialyllactoses saturate the binding sites of the lectin, causing its reduced binding
to the immobilized SGP and so further confirms the fact that the α2,3SGP and α2,6SGP
show specifically binding activity to their corresponding protein, respectively.
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Figure 7. SPR sensorgrams of lectin binding to SGP: A. Lectin binding to α2,3SGP,
MAA pre-incubated with α2,3SL in concentration of a. 0.075 nM, b. 0.15 nM, c. 0.25
nM, d. 0.75 nM, e. MAA pre-incubated with 0.75 nM of α2,6SL; A1. Steady state
response of lectin binding to α2,3SGP; B. Lectin binding to α 2,6SGP, SNA preincubated with α2,6SL in concentration of a. 0.075 nM, b. 0.15 nM, c. 0.25 nM, d 0.75
nM, e. SNA pre-incubated with 0.75 nM of α2,3SL; B1. Steady state response of lectin
binding to α2,6SGP.
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4.3.5 Hemagglutinin binding to immobilized SGP monitored by SPR
With the binding specificity confirmed for immobilized SGPs, we next examined their
specific

binding

to

influenza

viral

hemagglutinins

(HAs)

of

avian

H5N1

(A/Anhui/1/2005(H5N1)) and human H3N2 (A/Brisbane/10/2007(H3N2)) with SPR
technique, which bind to α2,3SGP and α2,6SGP, respectively. Human and avian HA in
PBS buffer (pH 7.4) were injected over immobilized α2,3SGP and α2,6SGP,
respectively. As a result, avian HA showed stronger binding (response units) to α2,3SGP
(Fig 8Aa) than α2,6SGP (Fig 8Bd), and avian HA binds to α2,3SGP much stronger so
that there is no dissociation observed from α2,3SGP (Table 2). Also, when avian HA was
pre-incubated with both α2,6-sialylactose and α2,3-sialylactose, the binding affinity of
HA decreased rapidly compared to HA alone (Fig 8Ab, 8Ac), however, the dissociation
of avian HA pre-incubated with α2,3-sialylactose was 2 fold higher than that of avian HA
pre-incubated with α2,6-sialylactose (Table 2) indicating that avian HA binds strongly to
α2,3-linked sialic acid. On the other hand, human HA showed higher binding (response
units) to α2,6SGP (Fig 8Ba) than α2,3SGP (Fig 8Ad), the dissociation of human HA
from α2,3SGP is 25 fold higher than that from α2,6SGP (Table 2), indicating that human
HA detached more rapidly from α2,3SGP and binds strongly to α2,6SGP. When human
HA was pre-incubated with both α2,6-sialylactose and α2,3-sialylactose, the binding
affinity of human HA decreased rapidly compared to human HA alone (Fig 8Bb, 8Bc),
however, the dissociation of human HA pre-incubated with 2,6-sialylactose was 5 fold
higher than that of human HA pre-incubated with α2,3-sialylactose (Table 2) indicating
that human HA binds strongly to α2,6-linked sialic acid. Overall, these observations
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indicated that avian influenza virus HA has higher affinity to α2,3-linked sialic acid and
human virus to α2,6-linked sialic acid of the immobilized SGP.

Figure 8. SPR sensorgrams of HA binding to SGP: A. HA binding to α2,3SGP, a. avian
HA, b. avian HA pre-incubated with α2,6SL, c. avian HA pre-incubated with α2,3SL, d.
human HA; A1. Steady state response of HA binding to α2,3SGP; B. HA binding to
α2,6SGP, a. human HA, b. human HA pre-incubated with α2,6SL, c. human HA preincubated with α2,3SL, d. avian HA; B1. Steady state response of HA binding to
α2,6SGP.
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Table 2. HA binding to immobilized SGP monitored by SPR
Glycopolymer

HA type

kd (s-1)

Response (RU)

α2,3SGP

H5N1

nd

307.2

H5N1 + α2,3SL

6.5 x 10-3

212.4

H5N1 + α2,6SL

3.7 x 10-3

69.84

H3N2

1 x 10- 3

138.2

H3N2

4 x 10-5

502.2

H3N2 + α2,3SL

2 x 10-4

100.4

H3N2 + α2,6SL

7 x 10-4

135.1

H5N1

6 x 10-5

286.3

α2,6SGP

(nd: not detectable)

4.4 Conclusion
A chemoenzymatic synthesis of O-cyanate chain-end functionalized sialyllactosecontaining glycopolymers was developed via one-pot cyanoxyl mediated free radical
polymerization followed by enzymatic sialylation. The chain-end O-cyanate group of the
polymer provides an anchor for oriented and covalent immobilization of the
glycopolymer onto amine surface via isourea bond formation in mild condition, which
were used for glycoarray and biosensor applications. The specific binding activity of the
arrays were confirmed with α2,3- and α2,6-sialyl binding lectin together with inhibition
assays. Further, SPR-based glyco-sensor showed specific binding activity for lectins and
influenza hemagglutins (HA) as well. These oriented sialyloligo-macroligand derived
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glycoarray and SPR-based glyco-sensor are closely to mimic 3D nature presentation of
sialyloligosaccharides and will provide important high-throughput tools for virus
diagnosis and potential anti-viral drug candidates screening applications. In addition, the
chain-end functionalizable glycopolymers can be used for polymer-protein conjugation as
well.
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CHAPTER V
SUMMARY

As carbohydrates present on the cell surfaces act as biomolecular recognition markers
for a variety of important biological functions, including cell communications, cell
adhesion, fertilization, differentiation and immune response through specific interactions
with proteins, it is essential to carefully choose carbohydrate epitopes and study the
carbohydrate-protein interactions. Glycans structured into multivalent ligands in the form
of linear polymers, have potential microarray application to study the carbohydrate
binding molecules. Also the low affinity and specificity which is typical for monomeric
carbohydrate-protein

interactions

are

noticeably

enhanced

when

carbohydrate

components are present as multivalent ligands like glycopolymers. Besides carbohydrate
microarrays processes a wide variety of potential applications in glycomics including
rapid determination of binding profile of carbohydrate-binding proteins, detection of
specific antibodies for disease diagnosis, characterization of carbohydrate-cell
recognition events and the high-throughput screening of inhibitors to prevent
carbohydrate-protein interactions. On the other hand surface Plasmon resonance
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technique has several advantages in studying the bio-molecular interaction in real-time
with a minute amount of label free samples.
In this thesis study, oriented and multivalent glycomacroligands were designed and
developed based on a chain-end functionalized carbohydrate-containing polymer
(glycopolymer) for efficient proteomic applications.
First, the O-cyanate chain-end functionalized glycopolymer was synthesized via onepot cyanoxyl mediated free radical polymerization technique and there is no protection
and deprotection steps needed and thus is a straightforward approach. The chain-end Ocyanate group of the polymer provides an anchor for site-specific and covalent
immobilization of the glycopolymer onto any amine surface via isourea bond formation
in mild condition. An oriented glyco-marcroligand formation based on O-cyanate chainend functionalized glycopolymer with commercially available amine modified silica gel
and glass slide via isourea bond formation was demonstrated, respectively.
Second, an oriented and density controlled glyco-marcroligand array formation was
demonstrated by end-point immobilization of glycopolymer imprinted with boronic acid
ligands in different sizes. Briefly, O-cyanate chain-end functionalized glycopolymer was
pre-modified by phenylboronic acid-lysozyme, BSA and polyacrylamide ligands and then
immobilized onto amine-functionalized glass slide via isourea bond formation at pH 10.3,
followed by releasing the phenylboronic acid ligands at pH 7.4, respectively. Glycoarray
and SPR results confirmed the same trend of density-dependent binding of lectins.
Imprinted glyco-marcroligand showed more lecting binding than non-imprinted one, and
the phenylboronic acid-polyacrylamide imprinted glyco-marcroligand showed highest
lectin binding.
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Third, a chemoenzymatic synthesis of O-cyanate chain-end functionalized
sialyllactose-containing glycopolymers was developed via one-pot cyanoxyl mediated
free radical polymerization followed by enzymatic sialylation. The chain-end O-cyanate
group of the polymer provides an anchor for oriented and covalent immobilization of the
glycopolymer onto amine surface via isourea bond formation in mild condition, which
were used for glycoarray and biosensor applications. The specific binding activity of the
arrays were confirmed with α2,3- and α2,6-sialyl binding lectin together with inhibition
assays. Further, SPR-based glyco-sensor showed specific binding activity for lectins and
influenza hemagglutins (HA) as well.
The orientally immobilized multivalent glyco-macroligands could be used for will
provide important high-throughput tools for virus diagnosis and potential anti-viral drug
candidates screening applications.

In addition, the chain-end functionalizable

glycopolymers can be used for polymer-protein conjugation as well.
.
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CHAPTER VI

FUTURE PERSPECTIVES

Overall, in this study, oriented multivalent glycopolymer has been developed and
could be used to study carbohydrate-protein interactions and thus are expected to
constitute a core strategy of rapidly and sensitively identifying carbohydrate binding
proteins. Also the immobilized sialyated glycopolymer was used to study the binding
affinities of both avian and human influenza viral recombinant hemagglutinin proteins. In
future, the potential of the oriented glyco-macroligad for analyzing influenza viral
hemagglutinin should be investigated by mass spectrometry technique. Mass
spectrometry has served an important role in the characterization of a range of viral and
bacterial pathogens over several decades.1-6 It has been recruited to characterize viral
proteins,7-9

their

posttranslational

modifications10

from

disulphide

bonds

to

glycosylation11-12 follow mutations in these proteins13 that result from replication errors
or the trading of genetic material from one strain to another, and assess viral structure
through studies of protein interactions and assemblies14-16 and the binding of antiviral
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drugs.17 Mass spectrometry offers advantages for characterizing the influenza virus in
terms of its genetic character, viral protein character, antigenicity, and for the quantitation
of viral proteins and antiviral drugs.18
In future, both α,2-3 and α,2-6 linked sialylglycopolymers will be immobilized
onto silica gel for HA and its proteolysis product isolation. For this study HA will be
digested and followed by isolation with oriented glyco-macroligand on silica gel and
subsequent mass spectrometry analysis so as to seek the sialic acid-binding residue,
conserved residue and peptide segments that can be used to subtype the influenza virus.
On the other hand, proteolysis of whole virus or gel-recovered influenza antigens19-20
combined with mass spectrometry provides a means with which to investigate these
proteins and subtype strains where the hemagglutinin surface antigens will be studied.
With the efficient influenza virus capture surfaces with receptor selectivity established
above, rapid isolation and identification of real influenza virus will be conducted.
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